# EDGAR Filing Document

**Accession Number:** 0001777921
**File Stem:** 0001437749-23-007871
**Filing Date:** 2023-3
**Character Count:** 197125
**Document Hash:** f777f1f3043c0d435c1b175d12a5902e
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001437749-23-007871.hdr.sgml**: 20230324

**ACCESSION NUMBER**: 0001437749-23-007871

**CONFORMED SUBMISSION TYPE**: DEF 14A

**PUBLIC DOCUMENT COUNT**: 20

**CONFORMED PERIOD OF REPORT**: 20230516

**FILED AS OF DATE**: 20230324

**DATE AS OF CHANGE**: 20230324

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** AvePoint, Inc.
- **CENTRAL INDEX KEY:** 0001777921
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-PREPACKAGED SOFTWARE [7372]
- **IRS NUMBER:** 834461709
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** DEF 14A
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-39048
- **FILM NUMBER:** 23760868

**BUSINESS ADDRESS:**
- **STREET 1:** 525 WASHINGTON BLVD
- **STREET 2:** SUITE 1400
- **CITY:** JERSEY CITY
- **STATE:** NJ
- **ZIP:** 07310
- **BUSINESS PHONE:** (201) 793-1111

**MAIL ADDRESS:**
- **STREET 1:** 525 WASHINGTON BLVD
- **STREET 2:** SUITE 1400
- **CITY:** JERSEY CITY
- **STATE:** NJ
- **ZIP:** 07310

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Apex Technology Acquisition Corp
- **DATE OF NAME CHANGE:** 20190528

**UNITED STATES**<br> **SECURITIES AND EXCHANGE COMMISSION**<br> **Washington, D.C. 20549**

**SCHEDULE 14A**

**(Rule 14a-101)**<br> **Proxy Statement Pursuant to Section 14(a) of the**<br> **Securities Exchange Act of 1934**

(Amendment No.)

Filed by the Registrant ☒

Filed by a Party other than the Registrant ☐

Check the appropriate box:

☐ Preliminary Proxy Statement

☐ Confidential, for Use of Commission Only (as permitted by Rule 14a-6(e)(2))

☒ Definitive Proxy Statement

☐ Definitive Additional Materials

☐ Soliciting Material Pursuant to §240.14a-12

**AVEPOINT, INC.**<br> (Name of Registrant as Specified in its Charter)

Payment of Filing Fee (Check all boxes that apply):

☒ No fee required.

☐ Fee paid previously with preliminary materials

☐ Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11

------

Notice of Annual Stockholders Meeting and

## Proxy Statement 2023

------

---

| | |
|:---|:---|
| **May 16, 2023** | **Virtual Meeting Site:** |
| **9:00 a.m. ET**  | <u>virtualshareholdermeeting.com/AVPT2023</u> |

---

![avpt20230323_def14aimg001.jpg](avpt20230323_def14aimg001.jpg)

![logo1.jpg](logo1.jpg)

------

## Notice of 2023 Annual Stockholders Meeting

---

| | |
|:---|:---|
| **Date** | May 16, 2023 |
| **Time** | 9:00 a.m. Eastern Time |
| **Virtual Meeting** | This year's meeting is a virtual stockholders meeting at <u>virtualshareholdermeeting.com/AVPT2023</u> |
| **Record Date** | March 20, 2023. Only stockholders of record at the close of business on the record date are entitled to receive notice of, and to vote at, the Annual Meeting. |
| **Proxy Voting** | **Make your vote count.** Please vote your shares promptly to ensure the presence of a quorum during the Annual Meeting. Voting your shares now via the Internet, by telephone, or by completing, signing, dating, and returning the enclosed proxy card or voting instruction form will save the expense of additional solicitation. If you wish to vote by mail, we have enclosed an addressed envelope with postage prepaid if mailed in the United States. Submitting your proxy now will not prevent you from voting your shares during the Annual Meeting, as your proxy is revocable at your option. We are requesting your vote to: |
| **Items of**<br> **Business** | • Elect the 3 director nominees named in this Proxy Statement;<br> • Approve, on a nonbinding advisory basis, the compensation paid to our named executive officers ("say-on-pay vote");<br> • Ratify the selection of Deloitte & Touché LLP as our independent auditor for fiscal year 2023; and<br> • Transact other business that may properly come before the Annual Meeting |
| **Address of Corporate Offices** | Corporate Headquarters: 525 Washington Blvd., Ste. 1400, Jersey City, New Jersey 07310<br> Primary Operations Center: 901 East Byrd Street, Ste. 900, Richmond, Virginia 23219 |
| **Meeting Details** | See Proxy Summary on Page 1 – Information About the Meeting for details. |

---

&nbsp;&nbsp;&nbsp; **Important notice regarding the availability of proxy materials for the Annual Meeting to be held on May 16, 2023.** Our 2023 Proxy Statement and 2022 Annual Report to Stockholders are available at ir.avepoint.com<br>

**By Order of the Board of Directors**

![avpt20230323_def14aimg002.jpg](avpt20230323_def14aimg002.jpg)

**Brian Michael Brown, Esq.**

Chief Legal and Compliance Officer,

and Secretary

Richmond, Virginia

March 24, 2023

------

**Table of Contents** 

---

| | |
|:---|:---|
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Page**  |
| **Proxy Summary** | &nbsp;&nbsp;&nbsp; **1**  |
| **Board of Directors** | &nbsp;&nbsp;&nbsp; **2**  |
| **Questions And Answers About These Proxy Materials And Voting** | &nbsp;&nbsp;&nbsp; **3**  |
| **Security Ownership** | &nbsp;&nbsp;&nbsp; **10**  |
| **Election of Directors (Proposal 1)** | &nbsp;&nbsp;&nbsp; **13**  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Nominees for Election as Directors  | &nbsp;&nbsp;&nbsp; 13  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Approval of Nominees  | &nbsp;&nbsp;&nbsp; 13  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Information About Nominees and Continuing Directors  | &nbsp;&nbsp;&nbsp; 13  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Directors For Election at the 2023 Annual Meeting of Stockholders  | &nbsp;&nbsp;&nbsp; 13  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Directors Whose Terms Expire in 2024  | &nbsp;&nbsp;&nbsp; 14  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Directors Whose Terms Expire in 2025  | &nbsp;&nbsp;&nbsp; 15  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Board Diversity  | &nbsp;&nbsp;&nbsp; 16  |
| **Corporate Governance** | &nbsp;&nbsp;&nbsp; **17**  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Board of Directors  | &nbsp;&nbsp;&nbsp; 17  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Board Leadership Structure  | &nbsp;&nbsp;&nbsp; 17  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Board Committees  | &nbsp;&nbsp;&nbsp; 18  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Board Risk Oversight  | &nbsp;&nbsp;&nbsp; 20  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Environmental, Social and Governance Matters  | &nbsp;&nbsp;&nbsp; 21  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Compensation Committee Interlocks and Insider Participation  | &nbsp;&nbsp;&nbsp; 25  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Director Nominations Policy  | &nbsp;&nbsp;&nbsp; 25  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Communications with the Board of Directors; Reporting Questionable Accounting, Internal Accounting Controls and Auditing Matters  | &nbsp;&nbsp;&nbsp; 26  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Stockholder Engagement  | &nbsp;&nbsp;&nbsp; 26  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Availability of Code of Conduct and Ethics, Bylaws, Corporate Governance Principles, and Committee Charters  | &nbsp;&nbsp;&nbsp; 27  |
| **Non-Employee Director Compensation** | &nbsp;&nbsp;&nbsp; **28**  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Current Total-Ownership of Non-Employee Directors  | &nbsp;&nbsp;&nbsp; 29  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Anti-Hedging and Anti-Pledging within Insider Trading Policy  | &nbsp;&nbsp;&nbsp; 30  |
| **Named Executive Officers** | &nbsp;&nbsp;&nbsp; **30**  |

---

i

------

---

| | |
|:---|:---|
| **Compensation Discussion and Analysis** | &nbsp;&nbsp;&nbsp; **31**  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Introduction  | &nbsp;&nbsp;&nbsp; 31  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2022 Say-on-Pay Results and Considerations  | &nbsp;&nbsp;&nbsp; 31  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Compensation Philosophy and Objectives  | &nbsp;&nbsp;&nbsp; 31  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; How Do We Determine Executive Pay?  | &nbsp;&nbsp;&nbsp; 33  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Elements of Executive Compensation  | &nbsp;&nbsp;&nbsp; 33  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Perquisites  | &nbsp;&nbsp;&nbsp; 37  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Additional Information on our Program  | &nbsp;&nbsp;&nbsp; 37  |
| **Report of the Compensation Committee of the Board of Directors of AvePoint, Inc.**  | &nbsp;&nbsp;&nbsp; **38**  |
| **Summary Compensation Table** | &nbsp;&nbsp;&nbsp; **38**  |
| **Outstanding Equity Awards at Fiscal-Year End** | &nbsp;&nbsp;&nbsp; **39**  |
| **Equity Compensation Plan Information** | &nbsp;&nbsp;&nbsp; **41**  |
| **The Company**'**s Compensation Policies and Practices as They Relate to Risk** | &nbsp;&nbsp;&nbsp; **42**  |
| **Advisory Vote on Executive Compensation (Proposal 2)** | &nbsp;&nbsp;&nbsp; **42**  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Approval of Proposal 2  | &nbsp;&nbsp;&nbsp; 42  |
| **Report of the Audit Committee of the Board of Directors of AvePoint, Inc.** | &nbsp;&nbsp;&nbsp; **43**  |
| **Independent Registered Public Accounting Firm** | &nbsp;&nbsp;&nbsp; **44**  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Fees  | &nbsp;&nbsp;&nbsp; 44  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Pre-Approval Policy  | &nbsp;&nbsp;&nbsp; 45  |
| **Ratification of Appointment of Independent Registered Public Accounting Firm for the 2023 Fiscal Year (Proposal 3)** | &nbsp;&nbsp;&nbsp; **45**  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Approval of Proposal 3  | &nbsp;&nbsp;&nbsp; 45  |
| **Transactions with Related Persons** | &nbsp;&nbsp;&nbsp; **46**  |
| **Delivery of Documents to Stockholders Sharing an Address** | &nbsp;&nbsp;&nbsp; **48**  |
| **Other Matters** | &nbsp;&nbsp;&nbsp; **49**  |

---

ii

------

**Proxy Summary** 

------

This summary highlights information contained elsewhere in this Proxy Statement. This summary does not contain all of the information you should consider. Please read the entire Proxy Statement carefully before voting.

---

| | | |
|:---|:---|:---|
| **Annual Stockholders Meeting** | **Annual Stockholders Meeting** | **Meeting Agenda** |
| **Date** <br>**Time**<br>**Place**<br>**Record Date** <br>**Voting** | Tuesday, May 16, 2023<br>9:00 a.m. Eastern Time<br>Virtual stockholders meeting at <u>virtualshareholdermeeting.com/AVPT2023</u><br>March 20, 2023<br>Stockholders as of the Record Date are entitled to vote. Each share of common stock is entitled to one vote for each director nominee and one vote for each of the proposals to be voted on. | <br> ■ Election of three directors<br> ■ Advisory vote on executive compensation<br> ■ Ratification of Deloitte & Touché LLP ("***Deloitte***") as our independent registered public accounting firm for fiscal year 2023<br> ■ Transact other business that may properly come before the meeting |
| **Date of Distribution** | The Notice Regarding the Availability of Proxy Materials (the "***Notice of Availability***"), this Proxy Statement, the 2022 Annual Report on Form 10-K (the "***Annual Report***") and the proxy card are first being made available or mailed on or about March 24, 2023. |  |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Voting Matters and Vote Recommendation** 

---

| | | | |
|:---|:---|:---|:---|
| **Proposal** | **Board**<br> **Recommendation** | **Reasons for Recommendation** | **More**<br> **Information** |
| 1. Election of three directors. | &nbsp;&nbsp;&nbsp;&nbsp;**FOR** | The Board of Directors of AvePoint Inc. (the "***Board***") and Nominating and Corporate Governance Committee believe that the three Board candidates possess the skills, experience, and diversity to effectively monitor performance, provide oversight, and advise management on AvePoint's long-term strategy. | Page 14 |
| 2. Non-binding advisory vote on executive compensation ("say-on-pay"). | &nbsp;&nbsp;&nbsp;&nbsp;**FOR** | The Board believes that AvePoint's executive compensation program aligns the interest of management and stockholders. | Page 45 |
| 3. Ratification of the appointment of Deloitte as AvePoint's independent registered public accounting firm for fiscal year 2023. | &nbsp;&nbsp;&nbsp;&nbsp;**FOR** | Based on the Audit Committee's assessment of Deloitte's qualifications and performance, the Board and the Audit Committee believe that its retention for fiscal year 2023 is in the best interests of AvePoint. | Page 50 |

---

------

**Board of Directors**

------

The following table provides summary information about each director.

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| **Director**<br> **Occupation** | **Age** | **Director** <br> **Since** | **Board** <br> **Independent** | **Other** <br> **Public** <br> **Boards** | **Committee** <br> **Memberships** | **Up for Re-**<br> **Election at** <br> **Current Annual** <br> **Meeting** |
|  |  |  |  | **AC**<br>**CC** | **NCGC** |  |
| **Xunkai Gong**,<br> Executive Chairman, *AvePoint, Inc.* | 60 | 2001 | No | 0 |  | No |
| **Tianyi Jiang**,<br> Chief Executive Officer, *AvePoint, Inc.* | 48 | 2004 | No | 0 |  | No |
| **Brian M. Brown**,<br> Chief Legal and Compliance Officer, Secretary,<br> *AvePoint, Inc.* | 50 | 2008 | No | 0 |  | Yes |
| **Jeff Epstein**,<br> Operating Partner, *Bessemer Venture Partners* | 66 | 2021 | Yes | 3<br> C  | M  | Yes |
| **Jeff Teper**,<br> Corporate Vice President,<br> *Microsoft, Inc.* | 58 | 2019 | Yes | 1<br> M  | C  | No |
| **John Ho**,<br> Founder and Chief Industrialist,<br> *Janchor Partners* | 46 | 2021 | Yes | 1<br> C F  |  | Yes |
| **Janet Schijns**,<br> CEO and Co-Founder,<br> *JS Group* | 60 | 2022 | Yes | 0<br> M  | M. | No |

---

---

| | | | |
|:---|:---|:---|:---|
| &nbsp;&nbsp; **AC** | Audit Committee | ![chair.jpg](chair.jpg) | Chair |
| &nbsp;&nbsp; **CC** | Compensation Committee | ![member.jpg](member.jpg) | Member |
| &nbsp;&nbsp; **NCGC** | Nominating and Corporate Governance Committee | ![finexpert.jpg](finexpert.jpg) | Financial expert |

---

------

**Questions and Answers About These Proxy Materials and Voting**

------

**What is AvePoint?**

AvePoint provides a cloud-native software platform that empowers organizations – of all sizes, in all regions, and across all industries – to optimize and secure the solutions that most commonly establish and underpin the digital workplace. As our customers seek to rapidly reduce costs, improve productivity and make more informed business decisions, they depend on our platform for data-driven insights, critical business intelligence and ongoing operational value through automation. AvePoint is a Microsoft Gold Certified Partner and a top Independent Software Vendor ranking in the top 5 in Microsoft, Inc.'s IP co-Sell program out of 3,000 participating partners worldwide.

AvePoint, Inc. ("***Legacy AvePoint***") was incorporated as a New Jersey corporation on July 24, 2001, was redomiciled as a Delaware corporation in 2006, and changed its name to "AvePoint Operations, Inc." in June 2021.

On July 1, 2021, Legacy AvePoint and certain members of Apex Technology Acquisition Corporation ("***Apex***"), the parties to the Apex Business Combination Agreement, consummated the transactions contemplated thereby (the "***Apex Business Combination***") and a number of qualified institutional buyers and accredited investors consummated their respective purchases of shares as contemplated by the Subscription Agreements, with Apex being renamed "AvePoint, Inc." On July 2, 2021, shares of common stock were officially listed under the ticker "AVPT" on the Nasdaq Global Select Market ("***Nasdaq***"). Subsequent to the consummation of the Apex Business Combination, on July 26, 2021, Legacy AvePoint's successor by merger AvePoint US LLC merged with and into AvePoint, Inc. with AvePoint, Inc. surviving.

**Who is soliciting my proxy?**

The Board is furnishing you this Proxy Statement to solicit proxies on its behalf to be voted at the Annual Meeting. The proxies also may be voted at any adjournments or postponements of the meeting. All properly executed written proxies, and all properly completed proxies submitted by telephone or by the Internet, that are delivered pursuant to this solicitation will be voted at the meeting in accordance with the directions given in the proxy, unless the proxy is revoked before the completion of voting at the meeting.

**Why did I receive a notice regarding the availability of proxy materials on the internet?**

Pursuant to rules adopted by the U.S. Securities and Exchange Commission (the "***SEC***"), we have elected to provide access to our proxy materials over the Internet. As a result, we are mailing a Notice of Availability to our stockholders instead of a paper copy of this Proxy Statement and our Annual Report to Stockholders (collectively, our "***proxy materials***"). The Notice of Availability contains instructions on how to access and review those documents over the Internet. We believe that this process will allow us to provide our stockholders with the information they need in a more timely manner, while reducing the environmental impact and lowering the costs of printing and distributing our proxy materials. Our Board is soliciting your proxy to vote at the 2023 Annual Meeting of Stockholders (the "***Annual Meeting***"), including at any adjournments or postponements of the Annual Meeting. All stockholders will have the ability to access the proxy materials on the website referred to in the Notice of Availability or request to receive a printed set of the proxy materials. Instructions on how to access the proxy materials over the internet or to request a printed copy may be found in the Notice of Availability.

We intend to mail the Notice of Availability on or about **March 24, 2023,** to all stockholders of record as of **March 20, 2023** (the "***Record Date***"), who are entitled to receive notice of, and to vote at, the Annual Meeting.

**Will I receive any other proxy materials by mail?**

No, you will not receive any other proxy materials by mail unless you request a paper copy of proxy materials. To request that a full set of the proxy materials be sent to you, please follow the applicable instructions on the Notice of Availability or voting instruction form, as applicable.

------

**How do I attend, participate in, and ask questions during the Annual Meeting?**

We will be hosting the Annual Meeting via live webcast. Any stockholder as of the Record Date can virtually attend, participate in, and ask questions during the Annual Meeting at <u>*www.virtualshareholdermeeting.com/AVPT2023*</u>. The meeting will start at **9:00 a.m., Eastern Time**, on **Tuesday, May 16, 2023**.

In order to log in to the virtual Annual Meeting, you will need a control number, which is included in the Notice of Availability or on your proxy card if you are a stockholder of record of shares of common stock, or included with your voting instruction card and voting instructions received from your broker, bank or other agent if you hold your shares of common stock in "street name." Instructions on how to virtually attend and participate are available at <u>*www.virtualshareholdermeeting.com/AVPT2023*</u>. We recommend that you log in a few minutes before 9:00 a.m., Eastern Time on Tuesday, May 16, 2023 to ensure you are logged in when the Annual Meeting starts. The webcast will open 15 minutes before the start of the Annual Meeting.

If you would like to submit a question during the Annual Meeting, you may log in to <u>*www.virtualshareholdermeeting.com/AVPT2023*</u> using your control number, type your question into the "Ask a Question" field, and click "Submit."

To help ensure that we have a productive and efficient meeting, and in fairness to all stockholders in attendance, you will also find posted our rules of conduct for the Annual Meeting when you log in prior to its start. These rules of conduct will include the following guidelines:

&nbsp;&nbsp;&nbsp;&nbsp;• How you may submit questions and comments electronically through the meeting portal during the Annual Meeting.

&nbsp;&nbsp;&nbsp;&nbsp;• Only stockholders of record as of the Record Date and their proxy holders may submit questions or comments.

&nbsp;&nbsp;&nbsp;&nbsp;• Please direct all questions to Dr. Tianyi Jiang, our Chief Executive Officer.

&nbsp;&nbsp;&nbsp;&nbsp;• Please include your name and affiliation, if any, when submitting a question or comment.

&nbsp;&nbsp;&nbsp;&nbsp;• Limit your remarks to one brief question or comment that is relevant to the Annual Meeting and/or our business.

&nbsp;&nbsp;&nbsp;&nbsp;• Related or similar questions may be grouped by topic by our management to save time and reduce redundancy.

&nbsp;&nbsp;&nbsp;&nbsp;• Questions may also be ruled as out of order if they are, among other things, irrelevant to our business, related to pending or threatened litigation, disorderly, repetitious of statements already made, or in furtherance of the speaker's own personal, political or business interests.

&nbsp;&nbsp;&nbsp;&nbsp;• Be respectful of your fellow stockholders and Annual Meeting participants.

&nbsp;&nbsp;&nbsp;&nbsp;• No audio or video recordings of the Annual Meeting are permitted.

**What if I have technical difficulties or trouble accessing the Annual Meeting?**

We will have technicians ready to assist you with any technical difficulties you may have accessing the Annual Meeting. If you encounter any difficulties accessing the Annual Meeting during the check-in or meeting time, please call the technical support number that will be posted at <u>*www.virtualshareholdermeeting.com/AVPT2023*</u> or at <u>*www.proxyvote.com*</u>. Technical support will be available starting at **9:00 a.m., Eastern Time** on **Tuesday, May 16, 2023**.

**Who can vote at the Annual Meeting?**

Only stockholders of record at the close of business on the Record Date**,** will be entitled to vote online at the Annual Meeting. On the Record Date, there were 190,339,282 shares of common stock outstanding and entitled to vote.

------

*Stockholder of Record: Shares Registered in Your Name*

If, on the Record Date, your shares were registered directly in your name with our transfer agent, Continental Stock Transfer & Trust Company, LLC, then you are a stockholder of record. As a stockholder of record, you may vote online during the Annual Meeting or by proxy in advance. Whether or not you plan to virtually attend the Annual Meeting, we urge you to vote your shares by proxy in advance of the Annual Meeting through the internet, by telephone or by completing, signing, dating and returning a printed proxy card that you may request or that we may elect to deliver at a later time to ensure your vote is counted.

*Beneficial Owner: Shares Registered in the Name of a Broker or Bank*

If, on the Record Date, your shares were held, not in your name, but rather in an account at a brokerage firm, bank, dealer or other similar organization, then you are the beneficial owner of shares held in "street name" and the Notice of Availability is being forwarded to you by that organization. The organization holding your account is considered to be the stockholder of record for purposes of voting at the Annual Meeting. As a beneficial owner, you have the right to direct your broker, bank or other agent regarding how to vote the shares in your account. You are also invited to virtually attend the Annual Meeting. However, since you are not the stockholder of record, you may not vote your shares online at the Annual Meeting unless you request and obtain a valid proxy from your broker, bank or other agent.

**What items will be voted on at the Annual Meeting and how does the Board recommend I vote on such items?**

---

| | | |
|:---|:---|:---|
| *Proposal 1: Election of Directors* (see page 13) | *<u>Voting Requirement</u>*: Directors will be elected by a plurality of the votes cast. This means that the director nominees who receive the greatest number of shares voted "For" their election are elected. | *<u>Board Recommendation</u>*: Our Board recommends a vote "For" each of the nominees named in this Proxy Statement.<br><u>Voting Choices</u>:<br> ● Vote "For" a nominee; or<br> ● "Withhold" a vote for a nominee. |
| *Proposal 2: Non-Binding Advisory Vote to Approve the Compensation of our NEOs* (see page 44) | *<u>Voting Requirement</u>*: Approval of this proposal will require the affirmative vote of holders of a majority of the shares of common stock present in person or represented by proxy and entitled to vote on such matter at the meeting. | *<u>Board Recommendation</u>*: Our Board recommends a vote "For" this proposal.<br><u>Voting Choices</u>:<br> ● Vote "For" the compensation of our NEOs;<br> ● Vote "Against" the compensation of our NEOs; or<br> ● "Abstain" from voting. |
| *Proposal 3: Ratification of the Selection of Independent Auditor* (see page 49) | *<u>Voting Requirement</u>*: Approval of this proposal will require the affirmative vote of holders of a majority of the shares of common stock present in person or represented by proxy and entitled to vote on such matter at the meeting. | *<u>Board Recommendation</u>*: Our Board recommends a vote "For" this proposal.<br><u>Voting Choices</u>:<br> ● Vote "For" the ratification;<br> ● Vote "Against" the ratification; or<br> ● "Abstain" from voting. |

---

**How do I vote?**

*Stockholder of Record: Shares Registered in Your Name*

If you are a stockholder of record, you may vote (1) online during the Annual Meeting or (2) in advance of the Annual Meeting by proxy through the internet, by telephone or by using a proxy card that you may request. Whether or not you plan to virtually attend the Annual Meeting, we urge you to vote by proxy to ensure your vote is counted. You may still virtually attend the Annual Meeting and vote online even if you have already voted by proxy.

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• To vote online during the Annual Meeting, follow the provided instructions to join the Annual Meeting at <u>*www.virtualshareholdermeeting.com/AVPT2023*</u> , starting at **9:00 a.m., Eastern Time** on **Tuesday, May 16, 2023**. The webcast will open 15 minutes before the start of the Annual Meeting. You will need to enter the company number and control number from the Notice of Availability or the printed proxy card to log in to the virtual Annual Meeting and to participate, ask questions and vote during the Annual Meeting.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• To vote in advance of the Annual Meeting through the internet, go to <u>*www.proxyvote .com*</u> to complete an electronic proxy card. You will be asked to provide the company number and control number from the Notice of Availability or the printed proxy card. Your internet vote must be received by **11:59 p.m., Eastern Time** on **Monday, May 15, 2023,** to be counted.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• To vote in advance of the Annual Meeting by telephone, dial 1-800-579-1639 using a touch-tone phone and follow the recorded instructions. You will be asked to provide the company number and control number from the Notice of Availability or the printed proxy card. Your telephone vote must be received by **11:59 p.m., Eastern Time** on **Monday, May 15, 2023,** to be counted.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• To vote in advance of the Annual Meeting using a printed proxy card that may be delivered to you, simply complete, sign and date the proxy card and return it promptly in the envelope provided. If you return your signed proxy card to us before the Annual Meeting, we will vote your shares as you direct.

*Beneficial Owner: Shares Registered in the Name of Broker or Bank*

If you are a beneficial owner of shares registered in the name of your broker, bank, or other agent, you should have received a Notice of Availability containing voting instructions from that organization rather than from AvePoint. Simply follow the voting instructions in the Notice of Availability to ensure that your vote is counted. To vote online at the Annual Meeting, you must obtain a valid proxy from your broker, bank or other agent. Follow the instructions from your broker, bank or other agent included with your proxy materials, or contact your broker, bank or other agent to request a proxy form.

**Internet proxy voting may be provided to allow you to vote your shares online, with procedures designed to ensure the authenticity and correctness of your proxy vote instructions. However, please be aware that you must bear any costs associated with your internet access, such as usage charges from internet access providers and telephone companies.**

**How many votes do I have?**

On each matter to be voted upon, you have one vote for each share of common stock you own as of the Record Date.

**What happens if I do not vote?**

*Stockholder of Record: Shares Registered in Your Name*

If you are a stockholder of record and do not vote by completing your proxy card, through the internet, by telephone or online at the Annual Meeting, your shares will not be voted.

------

*Beneficial Owner: Shares Registered in the Name of Broker or Bank*

If you are a beneficial owner and do not instruct your broker, bank or other agent how to vote your shares, the question of whether your broker or nominee will still be able to vote your shares depends on whether the particular proposal is deemed to be a "routine" matter. Brokers and nominees can use their discretion to vote "uninstructed" shares with respect to matters that are considered to be "routine," but not with respect to "non-routine" matters. Under applicable rules and interpretations, "non-routine" matters are matters that may substantially affect the rights or privileges of stockholders, such as mergers, stockholder proposals, elections of directors (even if not contested), executive compensation (including any advisory stockholder votes on executive compensation and on the frequency of stockholder votes on executive compensation), and certain corporate governance proposals, even if management-supported. Only the ratification of the selection of Deloitte as our independent registered public accounting firm for the fiscal year ended December 31, 2023, is considered a "routine" matter for which brokers, banks or other nominees may vote uninstructed shares. The other proposals to be voted on at the Annual Meeting are not considered "routine," so your broker, bank or other nominee cannot vote your shares on any of these other proposals unless you provide to your broker, bank or other nominee voting instructions for each of these matters. If you do not provide voting instructions on a non-routine matter, your shares will not be voted on that matter, which is referred to as a "broker non-vote." It is, therefore, important that you vote your shares.

**What if I return a proxy card or otherwise vote but do not make specific choices?**

If you return a signed and dated proxy card or otherwise vote without marking voting selections, your shares will be voted, as applicable, "For" the election of the nominees for director, "For" the Say-on-Pay proposal, and "For" the ratification of selection of Deloitte as our independent registered public accounting firm for the fiscal year ending December 31, 2023. If any other matter is properly presented at the meeting, your proxyholder (one of the individuals named on your proxy card) will vote your shares using his or her best judgment.

**Who is paying for this proxy solicitation?**

We will pay for the entire cost of soliciting proxies. In addition to these proxy materials, our directors and employees may also solicit proxies in person, or by other means of communication. Directors and employees will not be paid any additional compensation for soliciting proxies. We may also reimburse brokerage firms, banks and other agents for the cost of forwarding proxy materials to beneficial owners. In addition, we have retained Broadridge Financial Solutions, Inc. to assist in the mailing, collection and administration of the proxy materials.

**What does it mean if I receive more than one Notice of Availability?**

If you receive more than one Notice of Availability, your shares may be registered in more than one name or in different accounts. Please follow the voting instructions on each of the Notices of Availability you receive to ensure that all of your shares are voted.

**Can I change my vote after submitting my proxy?**

*Stockholder of Record: Shares Registered in Your Name*

Yes. You can revoke your proxy at any time before the final vote at the meeting. If you are the record holder of your shares, you may revoke your proxy in any one of the following ways:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• You may submit another properly completed proxy card with a later date.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• You may grant a subsequent proxy by telephone or through the internet.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• You may send a timely written notice that you are revoking your proxy to our Secretary at AvePoint, Inc. 901 East Byrd Street, Ste. 900, Richmond, VA 23219.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• You may virtually attend the Annual Meeting and vote online. Simply attending the meeting will not, by itself, revoke your proxy.

Your most current proxy card or telephone or internet proxy is the one that is counted.

------

*Beneficial Owner: Shares Registered in the Name of Broker or Bank*

If your shares are held by your broker, bank or other agent, you should follow the instructions provided by your broker, bank or other agent regarding changing or revoking your proxy.

**How are votes counted?**

Votes will be counted by the inspector of election appointed for the meeting.

**What are** "**broker non-votes**"**?**

As discussed above, when a beneficial owner of shares held in "street name" does not give voting instructions to his or her broker, bank or other securities intermediary holding his or her shares as to how to vote on matters deemed to be "non-routine," the broker, bank or other such agent cannot vote the shares. These unvoted shares are counted as "broker non-votes."

*As a reminder, if you are a beneficial owner of shares held in street name, in order to ensure your shares are voted in the way you would prefer, you <u>must</u> provide voting instructions to your broker, bank or other agent by the deadline provided in the materials you receive from your broker, bank or other agent*.

**What is the quorum requirement?**

A quorum of stockholders is necessary to hold a valid meeting. A quorum will be present if stockholders holding at least a majority of the voting power of the outstanding shares entitled to vote are present at the meeting online or represented by proxy. On the Record Date, there were 190,339,282 shares outstanding and entitled to vote. Thus, the holders of 94,116,828 shares must be present at the Annual Meeting by virtual attendance or represented by proxy at the meeting to have a quorum.

Your shares will be counted towards the quorum only if you submit a valid proxy (or one is submitted on your behalf by your broker, bank or other agent) or if you vote online at the meeting. Abstentions and Withholds will be counted towards the quorum requirement. Broker non-votes that are not voted on any matter will not be included in determining whether a quorum is present. If there is no quorum, the stockholders entitled to vote at the meeting by virtual attendance or represented by proxy shall have power to adjourn the meeting from time to time, without notice other than announcement at the meeting, until a quorum shall be present or represented. At such adjourned meeting at which a quorum shall be present or represented, any business may be transacted that might have been transacted at the meeting as originally notified. If the adjournment is for more than 30 days, or if after the adjournment a new record date is fixed for the adjourned meeting, a notice of the adjourned meeting shall be given to each stockholder of record entitled to vote at the meeting.

**How can I find out the results of the voting at the Annual Meeting?**

Preliminary voting results will be announced at the Annual Meeting. In addition, final voting results will be published in a current report on Form 8-K that we expect to file within four business days after the Annual Meeting. If final voting results are not available to us in time to file a Form 8-K within four business days after the meeting, we intend to file a Form 8-K to publish preliminary results and, within four business days after the final results are known to us, file an additional Form 8-K to publish the final results.

**Can I examine the list of stockholders as of the Record Date?**

Stockholders at the close of business on the Record Date may examine a list of common stockholders as of the Record Date for any purpose germane to the Annual Meeting for ten days preceding the Annual Meeting, at our offices at 901 E. Byrd Street, Suite 900, Richmond, Virginia 23219. If you would like to view the stockholder list, please contact our Investor Relations Department at ir@avepoint.com to schedule an appointment.

------

**When are stockholder proposals and director nominations due for next year**'**s Annual Meeting?** 

*<u>Proposals Pursuant to Rule 14a-8</u>*: For any proposal to be considered for inclusion in our proxy statement and form of proxy for submission to the stockholders at an annual meeting, it must be submitted by the stockholder in writing to our Secretary at AvePoint, Inc., 901 East Byrd Street, Ste. 900, Richmond, VA 23219 and comply with the requirements of Rule 14a-8 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). Proposals submitted in accordance with Rule 14a-8 of the Exchange Act for inclusion in our proxy statement for the 2024 Annual Meeting (presently anticipated to be held on May 16, 2024) must be received by our Secretary no later than November 25, 2023.

*<u>Nominations or Other Proposals Under Our Bylaws</u>*: Our By-Laws also set forth the procedures that a stockholder must follow to nominate a candidate for election as a director or to propose other business for consideration at stockholder meetings, in each case, not submitted under Rule 14a-8 of the Exchange Act. In each case, notices of a nomination or proposal must be delivered to us not less than 90 days and not more than 120 days prior to the date for the preceding year's annual meeting of stockholders; provided, however, that in the event that the annual meeting is called for a date that is more than 30 days before or more than 60 days after such anniversary date, notice by the stockholder to be timely must be so received not earlier than the close of business on the 120<sup>th</sup> day before the meeting and not later than the later of (x) the close of business on the 90<sup>th</sup> day before the meeting or (y) the close of business on the 10<sup>th</sup> day following the day on which public announcement of the date of the annual meeting is first made by us. Accordingly, to be timely for the 2024 Annual Meeting of Stockholders, assuming the meeting is held on or about May 16, 2024, a stockholder's notice must be delivered to or mailed and received by our Secretary not earlier than January 17, 2024, and not later than February 16, 2024.

------

**Security Ownership** 

------

The following table presents, as of **March 20, 2023**, information based upon AvePoint's records and filings with the SEC regarding beneficial ownership of its common stock by the following persons:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;■ each person known to AvePoint to be the beneficial owner of more than 5% of the common stock;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;■ each director and each nominee to the Board;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;■ each executive officer of AvePoint named in the Summary Compensation Table following the Compensation Discussion and Analysis section of this Proxy Statement; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;■ all directors and executive officers of AvePoint as a group.

As of **March 20, 2023**, there were 190,339,282 shares of our common stock outstanding. Beneficial ownership is determined according to the rules of the SEC, which generally provide that a person has beneficial ownership of a security if he, she or it possesses sole or shared voting or investment power over that security, including options and Warrants that are currently exercisable or exercisable within 60 days.

Beneficial ownership is determined according to the rules of the SEC, which generally provide that a person has beneficial ownership of a security if he, she or it possesses sole or shared voting or investment power over that security, including options and restricted stock units ("***RSUs***") that are currently exercisable or vested or that will become exercisable or vest within 60 days. This table is based upon information supplied by officers, directors and principal stockholders and Schedules 13G or 13D filed with the SEC. Unless otherwise indicated in the footnotes to this table and subject to community property laws where applicable, we believe that all persons named in the table have sole voting and investment power with respect to all shares of common stock beneficially owned by them. The beneficial ownership percentages set forth in the table below are based on 190,339,282 shares of common stock issued and outstanding as of March 20, 2023, *plus* the number of shares as to which such person has the right to acquire voting or investment power as of or within 60 days after March 20, 2023.

---

| | | |
|:---|:---|:---|
| **Name of Beneficial Owner \*** | **Amount and Nature of** <br> **Beneficial Ownership** | **Percent of**<br> **Class (%) <sup>(1)</sup>** |
| *5% or Greater Stockholders:* |  |  |
| Entities Affiliated with Sixth Street**<sup>(2)</sup>** | 28500592 | 14.97% |
| Zhijian Lu**<sup>(3)</sup>** | 19673846 | 10.34% |
| James Zhu**<sup>(4)</sup>** | 11328280 | 5.95% |
| The Vanguard Group, Inc. **<sup>(5)</sup>**  | 13397219 | 7.04% |
|  | **72899937** | **38.30%** |
| *Executive Officers and Directors:* |  |  |
| Xunkai Gong**<sup>(6)</sup>** | 20715449 | 10.88% |
| Tianyi Jiang**<sup>(7)</sup>** | 19599054 | 10.30% |
| Brian Michael Brown**<sup>(8)</sup>** | 2566642 | 1.35% |
| Jeff Epstein**<sup>(9)</sup>** | 1094422 | 0.57% |
| John Ho**<sup>(10)</sup>** | 4266720 | 2.24% |
| Jeff Teper**<sup>(11)</sup>** | 496843 | 0.26% |
| James Caci**<sup>(12)</sup>** | 200896 | 0.09% |
| Janet Schijns**<sup>(13)</sup>** | 34232 | 0.02% |
| All executive officers and directors as a group (8 persons)<sup>(14)</sup> | **48974258** | **25.72%** |

---

------

\* Unless otherwise indicated, the business address of each of the directors, executive officers and 5% or greater stockholders of the Company is C/O AvePoint, Inc., 525 Washington Blvd, Suite 1400 Jersey City, NJ, 07310.

<sup>(1)</sup> The percentage of beneficial ownership as to any person as of March 17, 2023 (the "***Ownership Date***") is calculated by dividing the number of shares beneficially owned by such person, which includes the number of shares as to which such person has the right to acquire voting or investment power as of or within 60 days after March 17, 2023, by the sum of the number of shares outstanding as of March 17, 2023 plus the number of shares as to which such person has the right to acquire voting or investment power as of or within 60 days after March 17, 2023. Consequently, the denominator used for calculating such percentage may be different for each beneficial owner. Except as otherwise indicated below and under applicable community property laws, the Company believes that the beneficial owners of the Company's common stock listed in the table have sole voting and investment power with respect to the shares shown. In all cases, stock options and RSUs that are not scheduled to vest as of or within 60 days after the Ownership Date are excluded from this calculation.

<sup>(2)</sup> Consists of shares of common stock issued upon exchange for shares of Series C Convertible Preferred shares of AvePoint held by Avatar Investment Opportunities, LLC, which directly holds 13,300,276 shares of common stock, Avatar Investment Solutions (A), LLC, which directly holds 8,523,089 shares of common stock, and Avatar Investment Solutions 1, LLC, which directly holds 6,677,227 shares of common stock (together, the "***Sixth Street Holders***"). Redwood IV Finance 1, LLC is the managing member of Avatar Investment Opportunities, LLC. TCS Finance (A), LLC is the managing member of Avatar Investment Solutions (A), LLC, which directly holds 8,523,089 shares of common stock. TCS Finance 1, LLC is the managing member of Avatar Investment Solutions 1, LLC. TSSP Opportunities GenPar IV, L.P. is the manager of Redwood IV Finance 1, LLC. TSSP Capital Solutions GenPar, L.P. is the manager of each of TCS Finance (A), LLC and TCS Finance 1, LLC. Each of TSSP Opportunities GenPar IV, L.P. and TSSP Capital Solutions GenPar, L.P. is ultimately indirectly controlled by Sixth Street Partners Management Company, L.P., a Delaware limited partnership ("***Management Company***"). Management Company is managed by its general partner, whose managing member is Alan Waxman. Alan Waxman disclaims beneficial ownership over the reported securities, except to the extent of his pecuniary interest therein. The address for each of these entities is 2100 McKinney Avenue, Suite 1500, Dallas, Texas 72501. The principal business address for Mr. Waxman is c/o Sixth Street Partners, LLC, 345 California Street, Suite 3300, San Francisco, CA 94104.

<sup>(3)</sup> Consists of (i) 18,558,275 shares of common stock, (ii) 1,107,599 shares of common stock underlying options exercisable within 60 days of the Ownership Date and (iii) 7,972 shares of common stock issuable pursuant to the vesting of RSUs within 60 days of the Ownership Date. The 18,558,275 shares include (i) 57,602 shares held by Zhijian Lu, (ii) 1,608,724 shares held The Bridge Water Trust, (iii) 804,757 shares held by KEM Lily LLC, (iv) 6,542,236 shares held by Fire Stone Family Trust, (v) 7,131,475 shares held by KEM Phoenix LLC, (vi) 804,757 shares held by KEM Rose LLC and (vii) 1,608,724 shares held by The Cherry Tree Trust. Mr. Lu has sole voting and dispositive power with respect to the shares held in his name and shares underlying options. Mr. Lu shares voting and dispositive power with Yan Ji with respect to shares held by Fire Stone Family Trust, KEM Lily LLC, KEM Rose LLC and KEM Phoenix, LLC. Mr. Lu shares voting and dispositive power with Jeffrey Scott Bardsley with respect to shares held by The Bridge Water Trust. Mr. Lu shares voting and dispositive power with Wen Ji Bardsley with respect to shares held by The Cherry Tree Trust.

<sup>(4)</sup> Consists of (i) 10,717,309 shares of common stock and (ii) 375,758 shares of common stock underlying options exercisable within 60 days of the Ownership Date. The 10,717,309 shares include (i) 347,123 shares held by James Zu, (ii) 402,378 shares held by MZ-Theta LLC, (iii) 919,609 shares held by MZ-Omega1 Trust, (iv) 842,209 shares held by The Shanmiao Trust, (v) 1,207,145 shares held by MZ-Alpha LLC, (vi) 1,207,145 shares held by MZ-Beta LLC, (vii) 402,378 shares held by MZ-Delta LLC, (viii) 402,378 shares held by MZ-Eta LLC, (ix) 2,347,778 shares held by MZ-Gamma LLC, (x) 1,077,422 shares held by The Zhijian 2020 Trust, (xi) 898,479 shares held by MZ-Iota Revocable Trust, and (xii) 898,478 shares held by MZ-Kappa Revocable Trust. Mr. Zhu shares voting and dispositive power with Sharron Shanmiao Ma with respect to the shares held by MZ-Alpha LLC, MZ-Beta LLC, MZ-Delta LLC, MZ-Eta LLC, MZ-Gamma LLC, MZ-Theta LLC, MZ-Iota Revocable Trust and MZ-Kappa Revocable Trust. Mr. Zhu shares voting and dispositive power with Brian Zhu with respect to the shares held by The Shanmiao Trust. Mr. Zhu shares voting and dispositive power with Sharron Shanmiao Ma and Alec Zhu with respect to the shares held by The Zhijian 2020 Trust. Mr. Zhu has sole voting and dispositive power with respect to the shares held by MZ-Omega1 Trust and shares underlying options.

<sup>(5)</sup> Consists of 13,397,219 shares of common stock pursuant to the Schedule 13G filed with the SEC on February 9, 2023, disclosing the number of shares as of December 30, 2022. The principal business address for The Vanguard Group, Inc. is 100 Vanguard Boulevard, Malvern, PA 19355.

<sup>(6)</sup> Consists of (i) 17,296,641 shares of common stock, (ii) 3,370,976 shares of common stock underlying options exercisable within 60 days of the Ownership Date and (iii) 47,832 shares of common stock issuable pursuant to the vesting of RSUs within 60 days of the Ownership Date. The 17,296,641 shares include (i) 57,007 shares held by Mr. Gong, (ii) 4,696,958 shares held by Mr. Gong's affiliate Giocoso Holdings LLC, (iii) 804,757 shares held by Mr. Gong's affiliate Cadenza Holdings LLC, (iv) 239,431 shares held by Mr. Gong's affiliate Vivace Holdings LLC, each of which Mr. Gong may be deemed to beneficially own, (v) 2,011,112 shares held by The Purple Harbor Trust, for which Mr. Gong is the trustee, (vi) 2,011,112 shares held by The Purple Cove Trust, for which Mr. Gong is the trustee, and (vii) 7,276,264 shares held by G Sonata Trust, for which Mr. Gong is the trustee. Mr. Gong holds sole voting and dispositive power with respect to the shares held of record by each trust.

<sup>(7)</sup> Consists of (i) 15,663,010 shares of common stock, (ii) (iii) 3,888,212 shares of common stock issuable pursuant to options exercisable within 60 days of the Ownership Date and (iii) 47,832 shares of common stock issuable pursuant to the vesting of RSUs within 60 days of the Ownership Date. The 15,663,010 shares include (i) 11,797 shares held by Mr. Jiang, (ii) 3,902,404 shares held by Mr. Jiang's affiliate River Valley Ltd., (iii) 2,633,766 shares held by Red Kite LLC, each of which Mr. Jiang may be deemed to beneficially own, (iv) 1,784,664 shares held by the Capella 2021 GRAT, (v) 5,971,000 shares held by Capella 2022 GRAT ,(vi) 1,187,786 shares held by Capella 2022 GRAT II, for each of which Mr. Jiang is the trustee, and (vii) 172,000 shares held by Mr. Jiang's spouse.

<sup>(8)</sup> Consists of (i) 1,094,192 shares of common stock, (ii) 804,520 shares of common stock issuable pursuant to options exercisable within 60 days of the Ownership Date and (iii) 13,712 shares of common stock issuable pursuant to the vesting of RSUs within 60 days of the Ownership Date.

<sup>(9)</sup> Consists of (i) 1,060,190 shares of common stock and (ii) 34,232 shares of common stock issuable pursuant to the vesting of RSUs within 60 days of the Ownership Date.

------

<sup>(10)</sup> Consists of (i) 216,598 shares of common stock, (ii) 34,232 shares of common stock issuable pursuant to the vesting of RSUs within 60 days of the Ownership Date and (iii) 4,015,890 shares of common stock issued in exchange for outstanding Legacy AvePoint common stock held by Mr. Ho's affiliate, Balmoral Blue Limited. Mr. Ho and his wife, Anita Hong, may be deemed to beneficially own these securities.

<sup>(11)</sup> Consists of (i) 16,598 shares of common stock and (ii) 446,013 shares of common stock issuable pursuant to options exercisable within 60 days of the Ownership Date.

<sup>(12)</sup> Consists of (i)144,975 shares of common stock, (ii) 20,738 shares of common stock issuable pursuant to options exercisable within 60 days of the Ownership Date and (iii) 35,183 shares of common stock issuable pursuant to the vesting of RSUs within 60 days of the Ownership Date.

<sup>(13)</sup> Consists of 34,232 shares of common stock issuable pursuant to the vesting of RSUs within 60 days of the Ownership Date.

<sup>(14)</sup> The shares of common stock shown as beneficially owned by all directors and executive officers as a group include a total of 9,466,164 RSUs and stock options they have the right to exercise as of or within 60 days after the Ownership Date, and exclude 6,485,197 RSUs and stock options that are not scheduled to vest as of or within 60 days after the Ownership Date.

------

**Election of Directors** 

**(Proposal 1)** 

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Nominees for Election as Directors** 

The Company's Second Amended and Restated Certificate of Incorporation (as amended, the "***Certificate of Incorporation***"), provides that the Board is to be divided into three classes of directors, with the classes to be as nearly equal in number as possible. The current terms of office of the three current classes of directors expire at this Annual Meeting, at the annual meeting of stockholders in 2024 and at the annual meeting of stockholders in 2025, respectively. Upon the expiration of the term of office of each class, the nominees for such class will be elected for a term of three years to succeed the directors whose terms of office expire.

In accordance with the recommendation of the Nominating and Corporate Governance Committee, Mr. Brown, Mr. Epstein and Mr. Ho have been nominated by the Board for election to the class with a three-year term that will expire at the annual meeting of stockholders in 2026. Each is an incumbent director.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Approval of Nominees** 

Approval of the nominees requires a plurality of the votes cast at the Annual Meeting, at which a quorum is present. The term "Plurality" for purposes of election of directors means that the nominees who receive the greatest number of votes for each open seat will be elected. Votes may be cast in favor of the election of directors or withheld. Votes that are withheld will be counted for the purposes of determining the presence or absence of a quorum but will have no effect on the election of directors. The election of directors is a non-routine matter; therefore, brokers, banks and other nominees may not vote their shares in favor of director nominees if they have not received voting instructions from the beneficial owners of the shares. Unless authority to do so is withheld, it is the intention of the persons named in the proxy to vote such proxy **FOR** the election of each of the nominees. If any of the nominees should become unable or unwilling to serve as a director, the persons named in the proxy intend to vote for the election of such substitute nominee for director as the Board may recommend. In lieu of designating a substitute, the Board may reduce the number of directors. It is not anticipated that any of the nominees will be unable or unwilling to serve as a director.

**The Board unanimously recommends that the stockholders of AvePoint vote FOR the election of the nominees to serve as directors.** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Information About Nominees and Continuing Directors** 

Biographical information concerning each of the nominees and each of the directors continuing in office is presented below.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Directors For Election at the 2023 Annual Meeting of Stockholders**

---

| | | |
|:---|:---|:---|
| &nbsp;&nbsp; **Director** | **Age** | **Director Since** |
| &nbsp;&nbsp; Brian M. Brown | 50 | 2008 |
| &nbsp;&nbsp; Jeff Epstein | 66 | 2019 |
| &nbsp;&nbsp; John Ho | 46 | 2021 |

---

------

---

| | |
|:---|:---|
| ![image01.jpg](image01.jpg) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ***Brian Michael Brown*** serves as AvePoint's Chief Legal and Compliance Officer and Secretary and was previously Legacy AvePoint's Chief Operating Officer, General Counsel and Secretary since 2016 and AvePoint's General Counsel since AvePoint began. Mr. Brown has been a director since 2005. Mr. Brown previously practiced law with the firm of McGuireWoods LLP for many years. Mr. Brown holds a bachelor's degree from the University of Michigan and a Juris Doctor from Michigan State University. We believe Mr. Brown is qualified to serve as a member of the Board because of his executive leadership experience, extensive legal background, familiarity with SaaS company operations and acumen with respect to international entity formation and legal operations. |

---

---

| | |
|:---|:---|
| ![image02.jpg](image02.jpg) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ***Jeff Epstein*** was Apex's Co-Chief Executive Officer, Chief Financial Officer and Secretary from its inception until the consummation of the Apex Business Combination, at which time he became a member of our Board. Since 2011, Mr. Epstein has been an operating partner with Bessemer Venture Partners, a venture capital firm. From 2008 to 2011, Mr. Epstein was executive vice president and chief financial officer of Oracle Corporation (NYSE: ORCL), a global technology company. Prior to joining Oracle, he served as chief financial officer of several public and private companies, including DoubleClick (sold to Google), King World Productions (sold to CBS) and Nielsen's Media Measurement and Information Group. Earlier in his career, he was an investment banker at The First Boston Corporation. Mr. Epstein is a lecturer at Stanford University. He serves on the boards of directors of Twilio, Okta and Couchbase, as well as the board of directors of Kaiser Permanente, a non-profit healthcare company. Within the last five years he previously served on the boards of directors of Booking Holdings (from 2003 to 2021), Shutterstock (from 2012 to 2021) and Poshmark (from 2018 to 2023). Mr. Epstein holds an MBA from the Stanford University Graduate School of Business and a bachelor's degree from Yale College. We believe Mr. Epstein is qualified to serve as a member of the Board because of his extensive industry and financial experience. |

---

---

| | |
|:---|:---|
| ![image03.jpg](image03.jpg) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ***John Ho*** has served as a member of our Board since the consummation of the Apex Business Combination. Since 2009, Mr. Ho has served as founder and chief industrialist investor of Janchor Partners. Since January 2018, Mr. Ho has served as a non-executive director for Vocus Group Limited, a telecommunications company listed on the ASX. From April 2017 to December 2019, he served as chairman of the board of directors of Bellamy's Organic, an organic infant milk formula and baby food company listed on the ASX. From July 2014 to July 2019, he served as deputy chairman, listing committee for the Hong Kong Exchanges and Clearing Limited. He serves on the boards of directors of Incitec Pivot limited. Mr. Ho received a Bachelor of Science degree in mathematics and a bachelor of commerce degree in finance from The University of New South Wales in Sydney, Australia. We believe Mr. Ho is qualified to serve as a member of the Board because of his financial experience and as a director of public companies. |

---

 **Directors Whose Terms Expire in 2024**

---

| | | |
|:---|:---|:---|
| &nbsp;&nbsp; **Director** | **Age** | **Director Since** |
| &nbsp;&nbsp; Xunkai Gong | 60 | 2001 |
| &nbsp;&nbsp; Jeff Teper | 58 | 2020 |

---

------

---

| | |
|:---|:---|
| ![image04.jpg](image04.jpg) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ***Xunkai Gong*** has served as our Executive Chairman since July of 2021. Prior to that, Mr. Gong served as Legacy AvePoint's Chairman and Co-Chief Executive Officer alongside Dr. Jiang since 2008. Before that, Mr. Gong served as Legacy AvePoint's Chief Executive Officer since Legacy AvePoint's incorporation in 2001. Mr. Gong holds a master's degree in computer engineering from University of Chinese Academy of Sciences, a master's degree in computer science from Southern University and Agricultural and Mechanical College at Baton Rouge, and a bachelor's degree in electrical and electronics engineering from Dalian University of Technology. We believe Mr. Gong is qualified to serve as a member of the Board due to his technical experience and leadership of AvePoint for the last twenty-two years. |

---

---

| | |
|:---|:---|
| ![image05.jpg](image05.jpg) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ***Jeff Teper*** has served as a member of the board of directors of Legacy AvePoint since December 2014 and a member of our Board since the consummation of the Business Consummation. Mr. Teper has worked at Microsoft Corporation since March 1992 and currently holds the title Corporate Vice President. Mr. Teper holds an MBA from Harvard Business School. He also holds a bachelor's degree from New York University. We believe Mr. Teper is qualified to serve as a member of the Board because of his executive leadership and industry experience and extensive experience in the Microsoft ecosystem. |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Directors Whose Terms Expire in 2025**

---

| | | |
|:---|:---|:---|
| &nbsp;&nbsp; **Director** | **Age** | **Director Since** |
| &nbsp;&nbsp; Tianyi Jiang | 48 | 2005 |
| &nbsp;&nbsp; Janet Schijns | 60 | 2022 |

---

---

| | |
|:---|:---|
| ![image06.jpg](image06.jpg) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ***Tianyi Jiang*** serves as our Chief Executive Officer. Prior to that, Dr. Jiang served as Legacy AvePoint's Co-Chief Executive Officer alongside Mr. Gong from 2008 to 2021 and as a director since 2005. Dr. Jiang has served as a member of our Board since the consummation of the Apex Business Combination. Dr. Jiang holds doctorate and master's degrees in Data Mining from New York University in addition to a bachelor's degree and master's degree in Electrical and Computer Engineering from Cornell University. We believe Dr. Jiang is qualified to serve as a member of the Board because of his executive leadership experience and extensive experience in the fields of cloud computing and SaaS. |

---

---

| | |
|:---|:---|
| ![image07.jpg](image07.jpg) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ***Janet Schijns*** is CEO and Co-Founder of JS Group, a go to market consultancy dedicated to achieving results in the technology channel. She is the founder of the #digitalnormal movement in the industry driving profitable change in the partner community. She was formerly Executive Vice President and Chief Merchant and Services Officer at Office Depot, where she led a major transformation to drive traction in services, generating recurring revenue from higher margin solutions. Prior to that, she was the Chief Channel Executive, Chief Marketing Technologist and led business products for Verizon Business. Additionally, Ms. Schijns led the channel organization for Motorola Enterprise and Government and is a noted and admired industry expert regularly appearing on the main stage at a variety of events. Additionally, Ms. Schijns currently serves on the board of directors for Ninjio, a security culture enablement provider which is helping to shut down business security breaches through employee empowerment. We believe Ms. Schijns is qualified to serve as a member of the Board because of her extensive expertise with SaaS channel organizations. |

---

------

**Board Diversity**

The matrix below summarizes certain of the key experiences, qualifications, skills, and attributes that our directors bring to the Board to enable effective oversight. The matrix is intended to provide a summary of our directors' qualifications and is not meant to be a complete list of each directors' strengths or contributions to the Board. Additional details on each director's experiences, qualifications, skills, and attributes are set forth in their respective biographies above.

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **Gong** | **Jiang** | **Brown** | **Epstein** | **Teper** | **Ho** | **Schijns** |
| **Skills and Experience** |  |  |  |  |  |  |  |
| Executive Leadership | ●  | ●  | ●  | ●  | ●  | ●  | ●  |
| Financial and Accounting |  |  |  | ●  | ●  | ●  | ●  |
| Global Business | ●  | ●  | ●  | ●  |  | ●  | ●  |
| Software Technology | ●  | ●  | ●  | ●  |  | ●  |  |
| Strategy and Innovation | ●  | ●  |  | ●  | ●  | ●  | ●  |
| Cybersecurity |  |  | ●  | ●  | ●  |  | ●  |
| Risk Management |  |  | ●  | ●  |  |  |  |
| Service and Operations | ●  | ●  |  | ●  | ●  |  | ●  |
| Corporate Administration and Oversight |  |  | ●  | ●  |  | ●  | ●  |
| **Tenure and Independence** |  |  |  |  |  |  |  |
| Tenure (years)<sup>(1)</sup> | 22 | 19 | 19 | 2 | 8 | 2 | 1 |
| Independence (Y/N) | N | N | N | Y | Y | Y | Y |
| **Demographics** – **Age** |  |  |  |  |  |  |  |
| Age | 60 | 48 | 50 | 66 | 58 | 46 | 60 |
| **Demographics** – **Gender Identity** |  |  |  |  |  |  |  |
| Male | ●  | ●  | ●  | ●  | ●  | ●  |  |
| Female |  |  |  |  |  |  | ●  |
| Non-Binary |  |  |  |  |  |  |  |
| Did Not Disclose |  |  |  |  |  |  |  |
| **Demographics** – **Racial Identity** |  |  |  |  |  |  |  |
| African American or Black |  |  |  |  |  |  |  |
| Alaskan Native or Native American |  |  |  |  |  |  |  |
| Asian | ●  | ●  |  |  |  | ●  |  |
| Hispanic or Latinx |  |  |  |  |  |  |  |
| Native Hawaiian or Pacific Islander |  |  |  |  |  |  |  |
| White |  |  | ●  | ●  | ●  |  | ●  |
| Two or More Races or Ethnicities |  |  |  |  |  |  |  |
| Did Not Disclose |  |  |  |  |  |  |  |
| **Demographics** – **LGBTQ+ Identity** |  |  |  |  |  |  |  |
| LGBTQ+ (Y/N) | N | N | N | N | N | N | N |
| Did Not Disclose |  |  |  |  |  |  |  |

---

<sup>(1)</sup> Includes tenure as a member of the board of directors of Legacy AvePoint.

------

**Corporate Governance** 

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Board of Directors**

The Board currently consists of seven (7) directors.

The Board has three standing committees: the Audit Committee, the Compensation Committee, and the Nominating and Corporate Governance Committee. During AvePoint's 2022 fiscal year, the Board held six (6) meetings, the Audit Committee held four (4) meetings, the Compensation Committee held four (4) meetings, and the Nominating and Corporate Governance Committee held four (4) meetings. During 2022, each director attended at least 75% of the aggregate of the total number of meetings of the Board and of each committee of the Board on which such director served.

It is AvePoint's policy that all directors should attend annual meetings of AvePoint's stockholders. In determining whether to recommend a director for re-election, the Nominating and Corporate Governance Committee considers the director's participation in and contributions to the activities of the Board, the results of the annual Board evaluation, past meeting attendance, and the other criteria for Board membership described in the Board's Corporate Governance Guidelines, available at <u>https://ir.avepoint.com/governance/governance-documents/default.aspx.</u> 

Each director is encouraged to be involved in continuing director education on an ongoing basis to enable him or her to better perform his or her duties and to recognize and appropriately address issues that arise. Board members are encouraged to attend seminars, conferences, and other continuing education programs designed especially for directors of public companies, including but not limited to, accredited director education programs.

&nbsp;&nbsp;&nbsp;&nbsp;**Board Leadership Structure**

*<u>Board Leadership Structure</u>.*

The Board is currently led by an Executive Chairman, Mr. Gong. The Board determined that Mr. Gong leading the Board was in the best interests of AvePoint and its stockholders because it allows AvePoint to benefit from Mr. Gong's significant experience and accumulated expertise in AvePoint's industry and AvePoint's internal policies, practices and procedures to effectively and expertly guide the Board. Mr. Gong's familiarity with AvePoint's executives reinforces that the Board and executives will operate with continuity and common purpose. The Board is further comprised of an independent Audit Committee Chairperson, an independent Compensation Committee Chairperson, and an independent Nominating and Corporate Governance Committee Chairperson. These independent positions align with AvePoint's corporate governance policies and practices and assure adequate independence of and oversight by the Board.

*<u>Director Independence</u>.<u> </u>*

The Board has affirmatively determined that all of the current directors, other than Mr. Gong, who is AvePoint's current Executive Chairman; Dr. Jiang, who is AvePoint's current Chief Executive Officer; and Mr. Brown, who is AvePoint's current Chief Legal and Compliance Officer and Secretary, are "independent" within the independence guidelines governing companies listed on the Nasdaq. Nasdaq Rule 5605 delineates the listing qualifications and requirements for a board of directors and committees, including the independence standards for board members. Nasdaq requires that a majority of the board of directors of a listed company be "independent" and further that all members of the audit, nominating and compensation committees be independent. Under Rule 5605, an "independent director" means a person other than an executive officer or employee of a company or any individual having a relationship which, in the opinion of the Board, would interfere with the exercise of independent judgment in carrying out the responsibilities of a director. In other words, the question of independence must ultimately be determined by the Board which must make an affirmative finding that a director is independent. As noted above, the Board has affirmatively determined that Mr. Epstein, Mr. Ho, Mr. Teper and Ms. Schijns are "independent" within the independence guidelines set forth in the applicable Nasdaq listing standards. However, the Nasdaq rules specify certain relationships that would disqualify a person from being considered independent. Stock ownership is not on the list and is not enough, without more, to preclude independence.

------

Nasdaq Rule 5605 species that the following people cannot be considered independent:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) a director who is, or at any time during the past three years was, employed by the company, provided however, interim employment of less than one year would not be a disqualifier as long as such employment had since terminated. In addition, employment by an entity that was later acquired by the company would not disqualify a director from being independent provided the former officer was not employed by the company after the acquisition;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) a director who accepted or who has a family member who accepted any compensation from the company in excess of $120,000 during any period of twelve consecutive months within the three years preceding the determination of independence, other than: (a) compensation for board or board committee service; (b) compensation paid to a family member who is an employee but not an executive of the company; (c) benefits under a tax-qualified retirement plan, or non-discretionary compensation; or (d) compensation received while acting as an interim officer as long as such employment lasted for less than a year and has since terminated. Options received for services should be valued using a commonly accepted option pricing formula, such as the Black-Scholes or binomial model at the time of grant. The option value is considered a payment upon grant even if the option does not immediately vest or if there are conditions to vesting or exercise. This prohibition is meant to capture any compensation that directly benefits the director or family member and as such would include political contributions to a campaign by either. However, it is not meant to capture ordinary course business transactions such as interest on an arm's-length loan;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii) a director who is a family member of an individual who is, or at any time during the past three years was, employed by the company as an executive officer;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iv) a director who is, or has a family member who is, a partner in (other than limited partner), or a controlling shareholder or an executive officer of, any organization to which the company made, or from which the company received, payments for property or services in the current or any of the past three fiscal years that exceed 5% of the recipient's consolidated gross revenues for that year, or $200,000, whichever is more, other than the following: (a) payments arising solely from investments in the company's securities; or (b) payments under non-discretionary charitable contribution matching programs;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(v) a director of the company who is, or has a family member who is, employed as an executive officer of another entity where at any time during the past three years any of the executive officers of the company serve on the compensation committee of such other entity; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(vi) a director who is, or has a family member who is, a current partner of the company's outside auditor, or was a partner or employee of the company's outside auditor who worked on the company's audit at any time during any of the past three years.

Reference to the "company" in Nasdaq Rule 5605 includes parents and subsidiaries or any other entities that the company consolidates financial statements with, including variable interest entities. Executive officer refers to any person covered by SEC Rule 16a-1(f) and in particular the company's president, principal financial officer, principal accounting officer, any vice-present in charge of a principal business unit, division or function or any officer or person who performs a policymaking function, which can include officers of a parent or subsidiary.

&nbsp;&nbsp;&nbsp;&nbsp;**Board Committees**

To support effective corporate governance, our Board delegates certain responsibilities to its committees, who report on their activities to the Board. These committees have the authority to engage legal counsel or other advisors or consultants as they deem appropriate to carry out their responsibilities.

Our Board has three standing committees:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;■ Audit Committee, chaired by Mr. Ho;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;■ Compensation Committee, chaired by Mr. Epstein; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;■ Nominating and Corporate Governance Committee, chaired by Mr. Teper.

------

The following table provides summary information about each committee followed by a summary of each committee's responsibilities. Each committee has a charter describing its specific responsibilities which can be found on our website at https://ir.avepoint.com/.

---

| |
|:---|
| *Employee Directors* |
| Xunkai Gong |
| Tianyi Jiang |
| Brian Michael Brown |
| *Non-Employee Directors* |
| Jeff Epstein<br> C<br> M |
| Jeff Teper <br> M<br> C |
| John Ho<br> C F |
| Janet Schijns<br> M |

---

C = Chair

M = Member

F = Financial Expert

Each of these committees plays an important role in the governance and leadership of our Board and each is chaired by an independent director with significant business experience.

*<u>Audit Committee.</u>*<u> </u>

During 2022, the Audit Committee of the Board was composed of three non-employee directors who meet the independence and expertise requirements of the Nasdaq listing standards: Mr. Ho, who is the Audit Committee Chairperson, Mr. Teper, and Ms. Schijns. Pursuant to SEC rules, the Board has determined that Mr. Ho is the "audit committee financial expert," as such term is defined for purposes of Item 407 of Regulation S-K promulgated by the SEC. The Audit Committee held four meetings during 2022.

The Audit Committee operates under a written charter that is reviewed annually. The Audit Committee is responsible, among its other duties, for engaging, overseeing, evaluating and replacing AvePoint's independent registered public accounting firm, pre-approving all audit and non-audit services by the independent registered public accounting firm, reviewing the scope of the audit plan and the results of each audit with management and the independent registered public accounting firm, reviewing the internal audit function, reviewing the adequacy of AvePoint's system of internal controls over financial reporting and disclosure controls and procedures, reviewing the financial statements and other financial information included in AvePoint's annual and quarterly reports filed with the SEC, reviewing the efficacy of AvePoint's information security and technology risks (including cybersecurity) and related policies and procedures, which include receiving quarterly reports from the Chief Legal and Compliance Officer ("***CLO***") who is tasked with monitoring cybersecurity risks, and exercising oversight with respect to AvePoint's Code of Conduct and Ethics and other policies and procedures regarding adherence to legal requirements. The Audit Committee has the authority to retain and terminate any third-party consultants and to obtain advice and assistance from internal and external legal, accounting and other advisers. The Audit Committee is authorized to delegate its authority to subcommittees as determined to be necessary or advisable. A current version of the Audit Committee charter is available on AvePoint's website at <u>https://ir.avepoint.com/governance/governance-documents/default.aspx</u>.

------

*<u>Compensation Committee</u>.*

During 2022, the Compensation Committee of the Board was composed of three non-employee directors who meet the independence requirements of the Nasdaq listing standards: Mr. Epstein, who is the Compensation Committee Chairperson, Mr. Teper, and Ms. Schijns. The Compensation Committee held four meetings during 2022.

The Compensation Committee operates under a written charter that is reviewed annually. Pursuant to its charter, the principal functions of the Compensation Committee are to review, determine and approve the compensation and benefits of AvePoint's Executive Officers, including the Executive Chairman and the other executive officers named in the Summary Compensation Table following the Compensation Discussion and Analysis section of this Proxy Statement, or "named executive officers," as well as other officers, and to administer AvePoint's employee benefit programs, including its 2021 Equity Incentive Plan (the "***2021 Plan***"), the 2016 Equity Incentive Plan ("***2016 Plan***"), and the 2006 Equity Incentive Plan ("***2006 Plan***"). The Compensation Committee is responsible for reviewing, adopting, amending and terminating incentive compensation and equity plans, severance agreements, profit sharing plans, bonus plans, change-of-control protections and any other compensatory arrangements for the executive officers and other senior management.

The Compensation Committee has the authority to retain and terminate any third-party compensation consultant and to obtain advice and assistance from internal and external accounting advisers. (See the *Compensation Discussion and Analysis* section of this Proxy Statement for information regarding the practices of the Compensation Committee, including the role of the officers and the Compensation Committee's compensation consultant in determining or recommending the amount and form of compensation paid to the named executive officers.) The Compensation Committee is authorized to delegate its authority to subcommittees as determined to be necessary or advisable. A current version of the Compensation Committee charter is available on AvePoint's website at <u>https://ir.avepoint.com/governance/governance-documents/default.aspx</u>.

*<u>Nominating and Corporate Governance Committee</u>.*

During 2022, the Nominating and Corporate Governance Committee was composed of three non-employee directors who meet the independence requirements of the Nasdaq listing standards: Mr. Teper, who is the Nominating and Corporate Governance Committee Chairperson, Mr. Epstein, and Ms. Schijns. The Nominating and Corporate Governance Committee held four meetings during 2022.

The Nominating and Corporate Governance Committee operates under a written charter that is reviewed annually. The Nominating and Corporate Governance Committee is responsible for recommending candidates for election to the Board and for making recommendations to the Board regarding Board size and membership qualifications, Board committees, and corporate organization. In addition, the Nominating and Corporate Governance Committee is responsible for making recommendations to the Board regarding corporate governance guidelines and related matters, including in relation to enterprise risk management, privacy, cybersecurity, personal data security, and corporate social responsibility.

The Nominating and Corporate Governance Committee has the authority to retain and terminate any search firm engaged to identify director candidates, and to obtain advice and assistance from outside advisors, as it deems appropriate in its sole discretion. The Nominating and Corporate Governance Committee is authorized to delegate its authority to subcommittees as determined to be necessary or advisable. A current version of the Nominating and Corporate Governance Committee charter is available on AvePoint's website at <u>https://ir.avepoint.com/governance/governance-documents/default.aspx</u>.

&nbsp;&nbsp;&nbsp;&nbsp;**Board Risk Oversight**

The Board recognizes the importance of effective risk oversight in running a successful business and in fulfilling its fiduciary responsibilities to AvePoint and its stockholders. While the Executive Chairman, CEO and other members of the executive leadership team are responsible for the day-to-day management of risk, the Board is responsible for ensuring that an appropriate culture of risk management exists within AvePoint and for setting the right "tone at the top," overseeing our aggregate risk profile, and assisting management in addressing specific risks, such as strategic and competitive risks, financial risks, brand and reputation risks, legal risks, regulatory risks, and operational risks.

------

The Board believes that its current leadership structure best facilitates its oversight of risk by combining independent leadership, through independent board committees, and majority independent board composition, with an experienced Executive Chairman who has extensive knowledge of the business, history, and the complex challenges AvePoint faces. The Executive Chairman's in-depth understanding of these matters and involvement in the day-to-day management of AvePoint uniquely positions him to promptly identify and raise key business risks to the Board, call special meetings of the Board when necessary to address critical issues, and focus the Board's attention on areas of concern. The Executive Chairman, independent committee chairs and other directors also are experienced executives who can and do raise issues for Board consideration and review, and who are not hesitant to challenge management. The Board believes there is a well-functioning and effective balance between the Executive Chairman, independent board committees, independent board members, and the executive officers, which enhance risk oversight.

The Board exercises its oversight responsibility for risk both directly and through its three standing committees. Throughout the year, the Board and each committee spend a portion of their time reviewing and discussing specific risk topics. The full Board is kept informed of each committee's risk oversight and related activities through regular attendance at all committee meetings by all directors. Strategic, operational and competitive risks also are presented and discussed at the Board's quarterly meetings, and more often as needed. On at least an annual basis, the Board conducts a review of our long-term strategic plans and members of senior management report on our top risks and the steps management has taken or will take to mitigate these risks. At each quarterly meeting, or more often as necessary, the CLO provides written and/or oral reports to the Board on the critical issues we face, and each officer reports on recent developments in their respective operating area. These reports include a discussion of business risks as well as a discussion regarding enterprise risk. In addition, at each quarterly meeting, or more often as necessary, the CLO updates the Board on material legal and regulatory matters.

The Audit Committee is responsible for reviewing the framework by which management discusses our risk profile and risk exposures with the full Board and its committees. The Audit Committee meets regularly with our CFO, CLO, independent auditor, internal auditor, and other members of senior management to discuss our major financial risk exposures, financial reporting, internal controls, credit and liquidity risk, compliance risk, and key operational risks. The Audit Committee meets regularly in separate executive sessions with the independent registered public accounting firm and internal auditor, as well as with committee members only, to facilitate a full and candid discussion of risk and other issues.

The Compensation Committee is responsible for overseeing human capital and compensation risks, including evaluating and assessing risks arising from our compensation policies and practices and ensuring executive compensation is aligned with performance. The Compensation Committee is also charged with monitoring our incentive and equity-based compensation plans, including employee benefit plans, reviewing and retaining compensation advisers, and considering the results of the non-binding advisory say-on-pay vote and determine what adjustments, if any, are necessary or appropriate for AvePoint to make to its compensation policies and practices in light of the results of such vote. The Compensation Committee meets regularly with the CLO and Chief Operating Officer ("***COO***") and other executive officers as well as in separate sessions with AvePoint's external compensation consultant to facilitate a full and candid discussion of executive performance and compensation.

The Nominating and Corporate Governance Committee oversees risks related to our overall corporate governance, including Board and committee composition, Board size and structure, Board compensation, director independence, and our corporate governance profile and ratings. The Nominating and Corporate Governance Committee also is actively engaged in overseeing risks associated with succession planning for the Board and management.

&nbsp;&nbsp;&nbsp;&nbsp;**Environmental, Social and Governance Matters** 

We recognize the importance of environmental, social and governance ("***ESG***") matters and how they impact our stakeholders. We believe appropriately responding to ESG issues is an important component of corporate social responsibility and comprehensive fiscal management. In light of the continued importance surrounding ESG matters, we are active in establishing and improving programs, practices and policies to maximize the benefit to AvePoint, our stockholders, our employees, and the communities we impact. We believe that strong ESG programs and practices are critical to attracting the best talent, executing on our strategies, maintaining a robust supplier and channel partner base, and innovating to meet our consumers' evolving expectations.

------

AvePoint's policies, practices and programs include engagement with external stakeholders to understand their priorities and obtain their feedback, coordination of relevant company projects and initiatives, and alignment with AvePoint's strategies and implementation. In 2022, in furtherance of its commitment to ESG matters, AvePoint designated the Board's Nominating and Corporate Governance Committee to oversee ESG matters, and the Nominating and Corporate Governance Committee approved the charter for an ESG committee within AvePoint with the involvement of internal stakeholders.

In 2023, we expect to continue to explore, and report on, our efforts to expand on ESG opportunities. Our future ESG disclosures will be informed by an internal ESG prioritization assessment to be undertaken in 2023, which will assess topics based on their potential impact to both business value creation and environmental and societal impact more broadly.

To that end, AvePoint is committed to transparent reporting on ESG matters and, therefore, has provided additional disclosure below related to the goals and relevant metrics of our ESG program to allow our stakeholders to be informed about our progress.

**1. Environmental**

***<u>Workplace Practices</u>***

Across our twenty offices, we strive to reduce our environmental footprint, operate more efficiently, and engage our personnel in social initiatives that directly impact their lives. To fulfill our aim of integrating environmental sustainability into everything we do, we have implemented numerous projects across our operations, including a company-wide paperless campaign and a computer recycling project, to reduce energy consumption and the use of non-renewable resources in our workplaces. Our Jersey City headquarters and our Arlington and Chicago offices are LEED certified, and our Singapore office is a Green Mark Platinum building. In addition, our Japan office takes many steps to maximize its energy efficiency, including:

● Maintenance and inspection to maintain efficient operation and performance of facilities using BEMS data;

● Operation with appropriate indoor temperature and humidity settings;

● Introduction of LEDs in common areas;

● Replacement of heat sources and air conditioners with high-efficiency equipment;

● Implementation of energy conservation meetings among operators, management companies, and construction companies; and

● Donation of carbon credits to the Tokyo Metropolitan Government under the cap-and-trade system (4,000 t-CO2)

***<u>Cloud Computing for the Good of All</u>***<u> </u>

AvePoint was an early mover to transition from traditional on-premises software solutions to software-as-a-service and hybrid deployments. Not only does cloud computing help meet the business needs of our customers, but it also has tremendous benefits to the environment, including greater energy efficiency, lower carbon emissions, and reduced carbon footprints.

In addition to many of AvePoint's own workers saving resources by working remotely, our software supports customers in offering remote opportunities to their workforces which helps them to reduce the environmental impacts of commuting and energy usage and waste production at physical worksites.

Looking forward, AvePoint is actively researching additional methods to reduce its carbon footprint and create a more sustainable future for the company and the communities we serve.

------

**2. Social**

As a global company, we have a tremendous opportunity – and responsibility – to do good. We strive to exemplify our core values of agility, passion and teamwork every day to ensure the success of our customers, partners, and stakeholders as well as make a positive impact in the communities where we live and work. To do this, we are committed to creating and empowering access to a variety of opportunities:

***<u>Philanthropy</u>***

As a global organization, AvePoint strives to create pathways to success for individuals and communities through education. At the heart of our work—volunteering, partnerships, donations, and advocacy—is the vision of a world where everyone, no matter where they live, which resources they have, or what challenging circumstances they face, has a path to self-reliance and resilience. Our partners range from organizations that advance education for underrepresented minorities across our industry, to those that champion public policies aimed at fostering innovation and growth. AvePoint is proud to support education as not only the great equalizer, but as the single most impactful catalyst to improving one's trajectory. In 2022, we continued our partnership with Girls Who Code, an organization that is committed to building the largest pipeline of future female engineers and has engaged over 500,000 girls, women, and nonbinary individuals through in-person programming. We also partnered with StepNow, an organization dedicated to equipping young people with the necessary tools to step into adulthood in the United Kingdom, to provide youth with a 1-week internship in our London offices to learn more about working in the technology field.

***<u>Inclusion, Diversity, Equity and Allyship.</u>***

AvePoint is proud to employ talent from many different backgrounds, experiences, and identities. Diversity and inclusion drive our success and is at the core of how we hire, communicate and collaborate to deliver value and excellence. AvePoint is committed to fostering an environment where people can bring their whole selves to work and feel a sense of belonging. Through our employee resource groups, internal mobility opportunities across the countries in which we operate, and external partnerships with underrepresented minority networks, we continue to work toward creating a workforce that represents the diversity of our customers and communities. Through our IDEA (Inclusion, Diversity, Equity and Allyship) Committee, in 2022 we launched our newest employee resource group dedicated to driving greater awareness and connection with military veterans. Our employee resource groups also led the Company's support of causes including The Trevor Project, the world's largest suicide prevention and crisis intervention organization for LGBTQ+ youth, and The National Center for Children and Families, a nonprofit child and family welfare agency with a commitment to serving poor, disadvantaged, abused neglected and abandoned children, youth and their families.

***<u>Supporting Agents of Change: Our Talent.</u>***

AvePoint is committed to investing in our people and nurturing a growth mindset across our organization. Our talent development philosophy builds upon the idea that business growth and success come from a culture of collaboration and creativity, and that our people should feel empowered to craft their careers, make an impact, and own their futures. Our portfolio of learning and development programs equips our leaders and managers with the skills and confidence to lead high-performing teams, and supports our individual contributors with the tools and resources to contribute impactfully in their roles from the moment they join AvePoint.

**3. Corporate Governance**

***<u>Social Responsibility Support from the Top</u>***

At AvePoint, our corporate governance practices support our core values of agility, passion, and teamwork. These practices provide a framework for the proper operation of our company, consistent with our stockholders' best interests and the requirements of law.

------

AvePoint is committed to managing our affairs consistent with the highest principles of business ethics and the corporate governance requirements of both federal law and Nasdaq, including the following:

● A majority of our board members are independent of AvePoint and its management;

● All members of our three board committees—the Audit Committee, the Compensation Committee, and the Nominating and Governance Committee—are independent;

● We have a clear code of business conduct to which all employees, officers and directors must adhere; and

● The charters of our board committees clearly establish their respective roles and responsibilities.

In 2022, in support of these priorities, AvePoint:

● Adopted formal Independence Standards for its Board and the Board's Audit Committee;

● Completed a full review of its Corporate Governance policies;

● Updated its Code of Conduct to include additional key policies and methods of reporting violations; and

● Introduced more robust and user-friendly platform for whistleblowers and other reporting.

***<u>Earning the World</u>***<u>'</u>***<u>s Trust</u>***

As a global company which is responsible to employees, stockholders, and customers, our vision for AvePoint is to build an environment in which we earn trust and confidence every day through enabling collaboration and innovation through our commitment to privacy, security, and transparency.

*Commitment to powering proactive data security programs*

AvePoint understands the importance of security and operational risk management and is committed to providing organizations with relevant metrics which help them make decisions that are proactive rather than reactive. When done in conjunction with policies, education and measurement, organizations can balance collaboration and transparency with data protection and privacy. We seek to earn trust not just with robust security and privacy practices, but with the way we operate and organize our business.

*Aligning to clear privacy principles*

AvePoint has a policy of transparency regarding our data collection, use, retention and sharing practices. It is our commitment to implement appropriate technical security measures to protect all AvePoint stakeholders and manage third party risk. AvePoint uses this foundation and discipline to develop market-leading privacy and security products and deliver world class customer service. Our software, processes and services have obtained industry-leading security and privacy certifications, including System and Organization Controls (SOC) 2 Type II, ISO 27001:2013 – Information Security, ISO 27017:015-Cloud Security, Information Security Registered Assessors (IRAP) Program and FedRAMP, and more. We have also implemented a rigorous program to assess our own vendors and suppliers.

*Advancing cybersecurity*

Cybersecurity is a central challenge as companies around the world embark on the digital transformation. Ransomware attacks have become one of the top security threats for organizations, especially as increased collaboration can lead to more vulnerabilities. The cost to recover stolen data can be millions of dollars, in addition to substantial reputational damage. AvePoint Ransomware Detection, and its Ransomware Warranty for MSP, which primarily serves small business clients, gives assurance that companies will be protected.

*Strengthening our offerings by first strengthening ourselves*

AvePoint has built a resilient, scalable and secure IT environment by investing in complementary industry leading technology and security solutions, in addition to utilizing our own software platform. In addition, AvePoint has built a corporate culture in which privacy and security are enablers of productivity, collaboration and trust; we balance the free flow of information with the risk of inappropriate access and/or disclosure; and we implement a risk-based approach to privacy and security that will allow us to maintain not only legal and regulatory compliance in the jurisdictions in which we operate, but also to facilitate business and innovation at AvePoint.

------

&nbsp;&nbsp;&nbsp;&nbsp;**Compensation Committee Interlocks and Insider Participation** 

Jeff Epstein was an officer of Apex prior to the closing of the Apex Business Combination. Following the consummation of the Apex Business Combination, no member of the Compensation Committee is or has been an officer or employee of AvePoint or any subsidiary of AvePoint. There are no interlock relationships as defined in applicable SEC rules. None of our executive officers currently serve, or have served during the last completed fiscal year, on the compensation committee or board of any other entity that has one or more executive officers that serve as a member of the board or compensation committee.

&nbsp;&nbsp;&nbsp;&nbsp;**Director Nomination Policy**

The Board has, by resolution, adopted a director nominations policy (the "***nominations policy***"). The purpose of the nominations policy is to set forth the process by which candidates for directors are selected. The nominations policy is administered by the Nominating and Corporate Governance Committee of the Board.

The Board does not currently prescribe any minimum qualifications for director candidates. Consistent with the criteria for the selection of directors approved by the Board, the Nominating and Corporate Governance Committee will take into account AvePoint's current needs and the qualities needed for Board service, including experience and achievement in business, finance, technology or other areas relevant to AvePoint's activities; reputation, ethical character and maturity of judgment; diversity of viewpoints, backgrounds and experiences; absence of conflicts of interest that might impede the proper performance of the responsibilities of a director; independence under SEC and Nasdaq rules; service on other boards of directors; sufficient time to devote to Board matters; ability to work effectively and collegially with other Board members; and diversity. In considering the diversity of candidates, the Nominating and Corporate Governance Committee considers an individual's background, professional experience, education and skill, race, gender and/or national origin. In the case of incumbent directors whose terms of office are set to expire, the Nominating and Corporate Governance Committee will review such directors' overall service to AvePoint during their term, including the number of meetings attended, level of participation, quality of performance and any transactions by such directors with AvePoint during their term. For those potential new director candidates who appear upon initial consideration to meet the Board's selection criteria, the Nominating and Corporate Governance Committee will conduct appropriate inquiries into their background and qualifications and, depending on the result of such inquiries, arrange for in-person meetings with the potential candidates.

The Nominating and Corporate Governance Committee may use multiple sources for identifying director candidates, including its own contacts and referrals from other directors, members of management, and AvePoint's advisers. The Nominating and Corporate Governance Committee has used in the past, and may use in the future, the services of an executive search firm to help identify candidates for directors who meet the qualifications outlined above. The search firm screens the candidates, conducts reference checks, prepares a biography of each candidate for committee review and assists in arranging interviews.

The Nominating and Corporate Governance Committee will also consider director candidates recommended by stockholders and will evaluate such director candidates in the same manner in which it evaluates candidates recommended by other sources. In making recommendations for director nominees for the annual meeting of stockholders, the Nominating and Corporate Governance Committee will consider any written recommendations of director candidates by stockholders received by the Secretary not less than 90 days and not more than 120 days prior to the date for the preceding year's annual meeting of stockholders; provided, however, that in the event that the annual meeting is called for a date that is more than 30 days before or more than 60 days after such anniversary date, to be timely, the written recommendation by the stockholder must be so received not earlier than the close of business on the 120<sup>th</sup> day before the meeting and not later than the later of (i) the close of business on the 90<sup>th</sup> day before the meeting or (ii) the close of business on the 10<sup>th</sup> day following the day on which public announcement of the date of the annual meeting is first made by us. Among many other requirements as set forth in the Company's Bylaws, recommendations must include the candidate's name and contact information and a statement of the candidate's background and qualifications, and must be mailed to AvePoint, Inc., 901 East Byrd Street, Ste. 901, Richmond, VA 23219, Attention: Secretary.

------

The nominations policy is intended to provide a flexible set of guidelines for the effective functioning of AvePoint's director nominations process. The Nominating and Corporate Governance Committee intends to review the nominations policy as it considers advisable and anticipates that modifications may be necessary from time to time as AvePoint's needs and circumstances evolve, and as applicable legal or listing standards change. The Nominating and Corporate Governance Committee may amend the nominations policy at any time.

In addition to recommending director candidates to the Nominating and Corporate Governance Committee, our Bylaws include procedures that a stockholder must follow to nominate director candidates for election to the Board or propose other business. The procedures are summarized under "Questions and Answers About These Proxy Materials and Voting - When are stockholder proposals and director nominations due for next year's Annual Meeting?" on page.

 **Communications with the Board of Directors; Reporting Questionable Accounting, Internal Accounting Controls and Auditing Matters** 

The Board welcomes communications from its stockholders and other interested parties and has adopted a procedure for receiving and addressing those communications. Security holders and other interested parties may communicate any concerns they may have about AvePoint directly and confidentially to either the full Board or the non-management directors as a group, or an individual director, by writing to: "Board of Directors" or "Non-Management Directors" or Name of Individual Director, AvePoint, Inc., 901 East Byrd Street, Ste. 901, Richmond, VA 23219, Attention: Secretary.

Stockholders and other interested parties may also make reports or provide other types of communication via the AvePoint Anonymous Reporting Hotline at <u>**https://www.lighthouse-services.com/avepoint**</u>, or by emailing the AvePoint Anonymous Reporting Email at <u>**reports@lighthouse-services.com**</u> (be sure to identify your organization in the email), or by calling the appropriate number below:

● English speaking USA and Canada: **833-950-4544** 

● Spanish speaking USA and Canada: **800-216-1288** 

● French speaking Canada: **855-725-0002** 

● Spanish speaking Mexico: **01-800-681-5340** 

● China-north, Beijing CNCG: **108-888** 

● China, PCR-South, Shanghai (China Telecom) **: 01-811** 

● All other countries: **800-603-2869** 

An independent third-party vendor maintains the AvePoint Anonymous Reporting Hotline, which is available 24 hours a day, 365 days a year. A caller wishing to be identified may indicate his or her name in the message. All calls are forwarded to the CLO. The CLO then reviews and forwards all communications to the Board member or members that the caller designates, except for those communications that are outside the scope of Board matters or duplicative of other communications previously forwarded to the intended recipients. The CLO will retain copies of all communications and maintain a record of whether the communications were forwarded and, if not, the reason why not.

 **Stockholder Engagement** 

We proactively engage with stockholders and other stakeholders throughout the year to learn their perspectives on significant issues, including AvePoint performance and strategy, corporate governance, executive compensation, and ESG topics. This engagement helps us better understand stockholder priorities and perspectives, gives us an opportunity to elaborate upon our initiatives and practices, and fosters constructive dialogue. We take feedback and insights from our engagement with stockholders and other stakeholders into consideration as we review and evolve our practices and disclosures, and further share them with our Board as appropriate.

------

&nbsp;&nbsp;&nbsp;&nbsp;**Availability of Code of Ethics and Business Conduct, Bylaws, Corporate Governance Guidelines, and Committee Charters**

We have adopted a Code of Ethics and Business Conduct (the "Code"), which is applicable to all of our directors, officers and employees, including our Executive Chairman, CEO, CLO, and CFO. Our Code, our Bylaws, our Corporate Governance Guidelines, and the charters of each standing committee of our Board are available free of charge at our Investor Relations website, https://ir.avepoint.com/. Copies of the foregoing are available in print for any stockholder that requests them. Requests for copies of these documents should be directed to Secretary, AvePoint, Inc., 901 East Byrd Street, Ste. 901, Richmond, VA 23219.

To the extent required by SEC rules, AvePoint intends to disclose any amendments to the Code, and any waiver of a provision of the Code with respect to the principal executive officer, principal financial officer, principal accounting officer or controller, or persons performing similar functions, on our web site referred to above within four business days following any such amendment or waiver, or within any other period that may be required under SEC rules from time to time.

**<u>Additional Information</u>**

At our Investor Relations website, https://ir.avepoint.com/, we make available free of charge a variety of information for investors. Our goal is to maintain the Investor Relations website as a portal through which investors can easily find or navigate to pertinent information about us, including:

● Our prospectuses, our annual reports on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K, and any amendments to those reports, as soon as reasonably practicable after we electronically file that material with or furnish it to the SEC at www.sec.gov.

● Announcements of investor conferences, speeches, presentations, and events at which our executives talk about our product, service, and competitive strategies.

● Press releases on quarterly earnings, product and service announcements, legal developments, and national and international news.

● Corporate governance information including our Articles of Incorporation, Bylaws, governance guidelines, committee charters, code of ethics and business conduct, whistleblower "open door" policy for reporting accounting and legal allegations, global corporate social responsibility initiatives, and other governance-related policies.

● Other news and announcements that we may post from time to time that investors might find useful or interesting, including with respect to our business strategies, financial results, and metrics for investors.

In addition to these channels, we use social media to communicate to the public. It is possible that the information we post on social media could be deemed to be material to investors. We encourage investors, the media, and others interested in AvePoint to review the information we post on the social media channels listed on our Investor Relations website.

------

**Non-Employee Director Compensation** 

------

The Compensation Committee is responsible for making recommendations to the Board regarding non-employee director compensation. In accordance with this authority, the Compensation Committee utilizes the independent compensation consultant, Compensia, Inc. ("***Compensia***"), to advise the Compensation Committee on matters related to director compensation.

The Company's director compensation program was reviewed by Compensia in 2022 relative to AvePoint's peer group. The Company's peer group was reviewed by Compensia prior to each compensation review, and in September 2022, Compensia provided the Compensation Committee (with respect to director compensation) a set of considerations for change, including proposed additions and deletions to the peer group.

After review, the Compensation Committee resolved to provide the following compensation to non-employee directors for their service as members of the Board and as members of the various Board committees effective as of May 9, 2022:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;■ An annual cash retainer of $36,000;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;■ A $4,000 cash incentive payment for each committee on which such non-employee director sits;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;■ A $15,000 cash incentive payment for service as the Audit Committee Chairperson;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;■ A $10,000 cash incentive payment for service as the Compensation Committee Chairperson;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;■ A $10,000 cash incentive payment for service as the Nominating and Corporate Governance Committee Chairperson;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;■ A $165,000 one-time restricted stock unit ("  ***RSU***") grant for the initial year of service on the Board; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;■ Annual $165,000 RSU grants for each additional year of service on the Board (subject to the annual approval of such grant amounts by the Compensation Committee), in each case vesting annually.

Non-employee directors receive cash and stock-based compensation under the AvePoint, Inc. 2021 Equity Plan.

We also reimburse our directors for reasonable out-of-pocket and travel expenses incurred in connection with their service on the Board.

The following table sets forth information regarding the compensation earned for service on our Board during the year ended December 31, 2022, by non-employee directors. Mr. Gong, Dr. Jiang, and Mr. Brown also serve as directors but did not receive any additional compensation for their service as directors. Their compensation as executive officers is set forth below in the "*Summary Compensation Table.*"

---

| | | | |
|:---|:---|:---|:---|
| **Non-Employee Director** | **Cash Retainer (US$)<sup>(1)</sup>** | **RSU Awards (US$) <sup>(2)</sup>** | **Total (US$)** |
| Jeff Epstein | $46667 | $165000 | $211667 |
| Jeff Teper | $49333 | $165000 | $214333 |
| John Ho | $47333 | $165000 | $212333 |
| Janet Schijns | $32000<sup>(3)</sup> | $165000 | $197000 |
| Stephen CuUnijeng<sup>(4)</sup> | $18000 | $0 | $18000 |

---

<sup>(1)</sup> This column represents the cash retainers, committee fees and committee chairperson fees, where applicable, paid to each non-employee director in 2022. For 2022, the committee chairperson fees were pro-rated based on May 9, 2022, effective date.

<sup>(2)</sup> The amounts reported in this column represent the accounting cost of RSU awards made to each director on the date of grant (May 3, 2022). The RSUs are subject to a one-year vesting period from the date of grant.

<sup>(3)</sup> The compensation that Ms. Schijns received in 2022 was for partial year service as she was elected as a director in May 2022.

<sup>(4)</sup> Mr. CuUnjieng did not stand for re-election in 2022.

------

---

| | | | |
|:---|:---|:---|:---|
| **Non-Employee Director** | **Number of Shares Subject**<br> **to Outstanding Options** | **Number of RSU** <br> **Awards** | **Total Common Stock** <br> **Shares Subject to** <br> **Equity Awards** |
| Jeff Epstein | - | 34232 | 34232 |
| Jeff Teper | 528593 | 34232 | 562825 |
| John Ho | - | 34232 | 34232 |
| Janet Schijns | - | 34232 | 34232 |
| Stephen CuUnjieng | 264262 | 0 | 264262 |

---

The annual director fee and the annual committee fees are paid in four equal quarterly installments in arrears on the first business day following each quarter of the fiscal year in which the eligible director completes board or committee service. Such fees are paid in the form of cash, provided that a director may elect to receive all or any portion of such fees in the form of a grant of RSUs (as determined by the Compensation Committee). The fiscal year for granting outside directors' equity is May 1 through April 30. The annual equity grants are typically made on the first business day in the month of May of each year.

All grants of RSUs vest one year after the grant is awarded, provided that the grants will immediately vest in the event of death, disability, retirement, or termination in connection with a change in control.

The compensation paid to our non-employee directors is designed to deliver compensation approximately 25% in cash and 75% in equity (assuming a director does not elect to receive additional equity in lieu of cash, as described above), with the objective of appropriately balancing the pay of non-employee directors for their service while linking their compensation closely to returns to stockholders through the potential for enhanced value from future stock price appreciation. Directors are also reimbursed for actual travel expenses.

The Company does not provide pensions, medical benefits or other benefit programs to non-employee directors.

 **Current Total Ownership of Non-Employee Directors**

As of March 20, 2023, our non-employee directors held the following outstanding equity in AvePoint:

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **Common** <br> **Stock** <br> **Shares** | **Number of** <br> **Shares** <br> **Subject to** <br> **Outstanding** <br> **Vested Options** | **Number of** <br> **Shares** <br> **Subject to** <br> **Outstanding**<br> **Unvested**<br> **Options** | **Number** <br> **of** <br> **Unvested** <br> **RSU** <br> **Awards<sup>(1)</sup>** | **Number** <br> **of** <br> **Vested** <br> **RSU** <br> **Awards** | **Aggregate** <br> **Amount of**<br> **Common**<br> **Stock Shares** <br> **Outstanding** | **Aggregate** <br> **Amount of**<br> **Common Stock** <br> **Shares** <br> **Beneficially** <br> **Owned<sup>(2)</sup>** |
| Jeff Epstein | 1043592 | 0 | 0 | 34232 | 16598 | 1060190 | 1094422 |
| Jeff Teper | 0 | 429500 | 99093 | 34232 | 16598 | 16598 | 496843 |
| John Ho | 4215890 | 0 | 0 | 34232 | 16598 | 4232488 | 4266720 |
| Janet Schijns | 0 | 0 | 0 | 34232 | 0 | 0 | 34232 |

---

<sup>(1)</sup> RSUs will vest on May 3, 2023.

<sup>(2)</sup> Beneficial ownership is determined according to the rules of the SEC, which generally provide that a person has beneficial ownership of a security if he, she or it possesses sole or shared voting or investment power over that security, including options and RSUs that are currently exercisable or vested or that will become exercisable or vest within 60 days.

------

&nbsp;&nbsp;&nbsp;&nbsp;**Anti-Hedging and Anti-Pledging within Insider Trading Policy**

In 2021, the Board also adopted, on a voluntary basis and in advance of final Dodd-Frank Act hedging rules, an insider trading policy (the "***Insider Trading Policy***") which is inclusive of anti-hedging and anti-pledging mechanics applicable to our employees, officers, employee directors, and non-employee directors. The Insider Trading Policy prohibits our directors from purchasing any financial instrument or entering into any transaction that is designed to hedge or offset any decrease in the market value of AvePoint equity (including, but not limited to, prepaid variable forward contracts, equity swaps, collars, or exchange funds), or pledging, hypothecating, or otherwise encumbering AvePoint equity as collateral for indebtedness. Any material waiver, variation, modification, or amendment to the Insider Trading Policy in connection with a proposed activity by an executive officer or director is subject to review and approval by the CLO and the Audit Committee.

**Named Executive Officers** 

------

The table below sets forth information concerning our executive officers covered in the "*Compensation Discussion and Analysis*" section of this Proxy Statement. We refer to them as the "named executive officers."

---

| | | |
|:---|:---|:---|
| **Executive Officer** | **Age** | **Position with Company** |
| Xunkai Gong | 60 | Executive Chairman |
| Tianyi Jiang | 48 | Chief Executive Officer |
| Brian M. Brown | 50 | Chief Legal and Compliance Officer |
| James Caci | 58 | Chief Financial Officer |

---

***Xunkai Gong*** has served as our Executive Chairman since July of 2021. Prior to that, Mr. Gong served as Legacy AvePoint's Chairman and Co-Chief Executive Officer alongside Dr. Jiang since 2008. Before that, Mr. Gong served as Legacy AvePoint's Chief Executive Officer since Legacy AvePoint's incorporation in 2001. Mr. Gong holds a master's degree in computer engineering from University of Chinese Academy of Sciences, a master's degree in computer science from Southern University and Agricultural and Mechanical College at Baton Rouge, and a bachelor's degree in electrical and electronics engineering from Dalian University of Technology.

***Tianyi Jiang*** was appointed as our Chief Executive Officer and a director in July of 2021. Prior to that, Dr. Jiang served as Legacy AvePoint's Co-Chief Executive Officer alongside Mr. Gong from 2008 to 2021 and as a director since 2005. Dr. Jiang holds doctorate and master's degrees in Data Mining from New York University in addition to a bachelor's degree and master's degree in Electrical and Computer Engineering from Cornell University.

***Brian M. Brown*** serves as AvePoint's Chief Legal and Compliance Officer and Secretary and was previously Legacy AvePoint's COO and General Counsel since 2016 and AvePoint's General Counsel since AvePoint's inception. Mr. Brown has been a director since 2008. Mr. Brown holds a bachelor's degree from the University of Michigan and a Juris Doctor from Michigan State University. Prior to joining AvePoint, Mr. Brown practiced as a securities and M&A attorney with the law firm of McGuireWoods LLP.

***James Caci*** was appointed as our Chief Financial Officer in August of 2021. In this role, Mr. Caci oversees all aspects of AvePoint's financial operations, provides quality insights for informed decision-making, achieves goals for financial transparency and integrity, and helps the company scale both organically and through acquisition. Mr. Caci has over 25 years of experience leading the strategic finance operations at both public and privately held SaaS and IT service companies. Prior to AvePoint, Mr. Caci served as CFO of Brand Value Accelerator, where he aligned the company to capitalize on the meteoric rise of Shopify and Conductor, Inc., among others. Mr. Caci has a BS in Business Administration from Montclair State University.

------

**Compensation Discussion and Analysis** 

------

&nbsp;&nbsp;&nbsp;&nbsp;**Introduction** 

This section describes AvePoint's compensation program for its named executive officers.

This Compensation Discussion and Analysis focuses on the material elements of our executive compensation program in effect for the 2022 fiscal year. It also provides an overview of our executive compensation philosophy and why we believe the program is appropriate for AvePoint and its stockholders. Finally, we discuss the Compensation Committee's methodology for determining appropriate and competitive levels of compensation for the named executive officers. Details of compensation paid to the named executive officers can be found in the tables below.

Our executive compensation program is intended to align the interest of our named executive officers with those of our stockholders by rewarding performance that meets or exceeds the goals the Board and Compensation Committee establish with the objective of increasing stockholder value. In line with our pay for performance philosophy, the total compensation received by our named executive officers will vary based on individual and corporate performance measured against performance goals. Our named executive officers' total compensation is comprised of a mix of base salary, annual cash incentive and long-term equity incentives.

&nbsp;&nbsp;&nbsp;&nbsp;**2022 Say-on-Pay Results and Considerations** 

The Company provides its stockholders the opportunity to cast an annual non-binding advisory vote on executive compensation (a "say-on-pay proposal"). The Company and AvePoint's Compensation Committee consider the outcome of AvePoint's say-on-pay proposal when making future compensation decisions for the executive officers of AvePoint. Although this vote is advisory (and therefore not binding on AvePoint), AvePoint, the Compensation Committee and the Board carefully review this result each year and consider it, along with other communications from stockholders relating to our compensation practices, in making future compensation decisions for executive officers of AvePoint. At our 2022 annual meeting, 99.3% of the shares present and entitled to vote supported to approve our say-on-pay proposal regarding 2021 compensation. Based on these results, the Compensation Committee believes the Company's compensation design and programs have strong stockholder support.

&nbsp;&nbsp;&nbsp;&nbsp;**Compensation Philosophy and Objectives** 

**What person or group is responsible for determining the compensation levels of named executive officers?** 

*The Role of the Compensation Committee.* The Compensation Committee, pursuant to its charter, reviews, determines and approves the compensation, including base salary, and annual and long-term incentives of AvePoint's Executive Chairman, CEO, the other named executive officers, as well as the other officers. Additionally, the Compensation Committee administers AvePoint's compensation programs, including the 2021 Plan and the 2016 Plan.

*The Role of Consultants.* The Compensation Committee has the authority to retain and terminate any third-party compensation consultant and to obtain advice and assistance from internal and external legal, accounting and other advisers. The Compensation Committee has the authority to compensate its outside advisers without obtaining approval of the Board. In accordance with this authority, the Compensation Committee retained Compensia in 2022 as the Compensation Committee's independent compensation consultant to advise the Compensation Committee on matters related to CEO and other officer compensation. The Compensation Committee assessed Compensia's work as required under rules of the SEC and concluded that it did not raise any conflicts of interest and that Compensia was independent within Nasdaq's listing standards.

------

The consultant's assignments are determined by the Compensation Committee Chairperson. At the request of the Compensation Committee Chairperson, the consultant assists in developing the peer group of companies and compensation surveys to be used for the competitive analyses, prepares the market analysis of named executive officer compensation, prepares a financial analysis of AvePoint's performance vis-à-vis the peer group and analyzes the relationship between CEO pay and company performance, constructs market competitive ranges of pay opportunity for base salaries, annual cash incentive targets, and long-term equity incentive awards for named executive officers, and reviews the annual and long-term incentive plans for linkage to key business objectives and company performance. The consultant advises the Compensation Committee as to the compensation of executive officers of AvePoint, but does not recommend any specific pay level changes for executive officers.

During 2022, the total fees paid to Compensia for services performed during 2022 relating to executive compensation were $81,429.67.

*The Role of Executives.* The Company's Executive Chairman, CEO, COO and CLO are actively involved in the executive compensation process. The CEO and COO review the performance of each of the named executive officers and, within the defined program parameters, recommend to the Compensation Committee base salary increases, annual incentive targets and long-term equity awards for such individuals. The COO and CLO ensure the executive compensation program attracts, retains, and motivates AvePoint's executive team and potential executive hires. The COO and CLO attend the meetings of the Compensation Committee, but do not participate in the Compensation Committee's executive sessions.

**What are AvePoint**'**s executive compensation principles and objectives?** 

The Compensation Committee believes that the structure of the compensation program for named executive officers should be designed to attract, motivate, and retain key talent to promote the long-term success of AvePoint, and to balance these objectives with a strong link to stockholder return and other measures of performance that drive total stockholder return.

The Company's overall executive compensation philosophy is that pay should be competitive with the relevant market for executive talent, be performance-based, vary with the attainment of specific objectives, and be closely aligned with the interests of AvePoint's stockholders. The core principles of AvePoint's executive compensation program include the following:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;■ *Pay competitively:* The Compensation Committee believes in positioning executive compensation at competitive levels necessary to attract and retain exceptional leadership talent. An individual's performance and importance to AvePoint can result in that individual's total compensation being higher or lower than AvePoint's target market position. The Compensation Committee regularly utilizes the assistance of the compensation consultant to provide information on market practices, programs, and compensation levels.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;■ *Pay-for-performance:* The Compensation Committee structures the executive compensation program to balance annual and long-term corporate objectives, including specific measures which focus on financial performance, with the goal of fostering stockholder value creation in the short and long-term.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;■ *Create an ownership culture:* The Compensation Committee believes that using equity compensation to instill an ownership culture effectively aligns the interests of management and the stockholders. To promote this alignment, the Compensation Committee granted equity awards in 2022 which were comprised of time-based stock options and time-based RSUs to provide incentives for named executive officers to enhance stockholder value.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;■ *Utilize a total compensation perspective:* The Compensation Committee considers all of the compensation components — base salary, annual cash incentive, long-term equity incentives, benefits and perquisites — in total.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;■ *Improved financial performance:* The Company aggressively pursues strategies intended to improve its financial and operational performance by expanding its product offerings, enhancing its sales channels, improving production performance, including quality, efficiency, capacity, and lowering costs. The Compensation Committee believes in utilizing a compensation program that appropriately rewards executives for the achievement of these objectives.

------

The COO, CLO and the Compensation Committee regularly review the executive compensation program and philosophy to assess whether the program promotes the objectives of enabling AvePoint to attract and retain exceptionally talented executives and to link total compensation to AvePoint's ability to meet its annual financial and non-financial goals and, in the longer term, to produce enhanced levels of total stockholder return. Based on such reviews, programmatic changes have been implemented at various times to enhance consistency of the various compensation elements with the program's philosophy.

 **How Do We Determine Executive Pay?** 

*Comparison Data:* Benchmarking in comparison to the peer group is one of several factors considered in the compensation process but is not in and of itself determinative. The relative position of an individual named executive officers in comparison to the peer group is based on their respective competencies, experience and performance. While we do not establish executive pay based solely on benchmarking data, we believe that our pay levels and practices should be within a range of competitiveness with our peer group and benchmarking provides us with an assessment of reasonableness and competitiveness; however, each individual's actual compensation is based on numerous factors including the individual's level of experience in the role and the annual and long-term performance of both AvePoint and the individual.

The Compensation Committee reviews target total direct compensation, which consists of base salary, target annual cash incentive, and long-term equity incentives, to a peer group of companies (the "peer group"). The Compensation Committee utilizes this comparison data for its named executive officer compensation because the Compensation Committee believes this is the best way to determine whether such compensation is competitive with AvePoint's labor market for executive talent.

*Peer Group:* The Compensation Committee takes into account a number of factors for each potential peer group company including, but not limited to, size (revenues, market capitalization and number of employees), nature of business (business comparators and similar customer base), organizational complexity and business model (span and scope of the organization), competition for executive talent (organizations from which executives may be recruited to and from) and location. While all of the aforementioned factors are taken into account, the Compensation Committee considered the most important factors to be size, nature of business and competition for executive talent as these provide the most meaningful insight into competitive practices.

In September 2022, Compensia completed an executive compensation benchmarking study.

&nbsp;&nbsp;&nbsp;&nbsp;**Elements of Executive Compensation** 

**<u>Base Salary</u>** 

Base salary is annual fixed cash compensation, and is a standard element of compensation, necessary to attract and retain talent. Base salary is the principal non-variable element of AvePoint's total compensation program.

Base salaries reflect each named executive officer's responsibilities, the impact of each named executive officer's position, and the contributions each named executive officer delivers to AvePoint.

Base salaries are determined by competitive levels in the market, based on AvePoint's peer group and the results of executive compensation surveys, for executives with comparable responsibilities and job scope. Base salary increases, if any, are based on individual performance, market conditions and company performance. To gauge market conditions, the Compensation Committee evaluates the peer group and market data compiled by its consultant. Base salaries are set following review of this data upon consideration of the named executive officer's experience, tenure, performance, and potential.

------

The annualized base salaries of the named executive officers are as follows:

---

| | | |
|:---|:---|:---|
| **Named Executive Officer** | **2021 Base** <br> **Salary** | **2022 Base** <br> **Salary** |
| Xunkai Gong | $400000 | $400000 |
| Tianyi Jiang | $450000 | $450000 |
| Brian Michael Brown | $350000 | $350000 |
| James Caci | $315000 | $315000 |

---

**<u>Annual Incentive Plan</u>** 

The Annual Incentive Plan ("***AIP***") is a cash incentive that provides our executive officers with the opportunity to be rewarded annually based on the achievement of AvePoint's key financial goals. The Compensation Committee sets the target annual cash bonus for each named executive officer as a percentage of the executive's annual base salary. Award opportunities are established at threshold, target and maximum levels. The maximum level for each performance criterion under the AIP is typically capped at 150% of target. The actual amount of the award is determined based on the level of achievement against each financial goal after the completion of the performance period. For 2022, the Compensation Committee approved the following target incentive percentages for each named executive officer:

---

| | |
|:---|:---|
| **Named Executive Officer** | **Target Incentive as a % of** <br> **Base Salary** |
| Xunkai Gong | 100% |
| Tianyi Jiang | 80% |
| Brian M. Brown | 100% |
| James Caci | 90% |

---

*2022 Goals, Target Setting and Results.* In February 2022, the Compensation Committee selected Total Revenue, Annual Recurring Revenue ("***ARR***") and Non-GAAP Operating Income as the key financial goals to determine the level of payout for each named executive officer. For purposes of this section "Non-GAAP Operating Income" means GAAP Operating Income plus stock-based compensation expense and the amortization of acquired intangible assets. The Compensation Committee set target goal values that aligned with the company's growth objectives and financial guidance. The goals, target values and financial results appear below:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| **Goal ($ in** <br> **millions)** | **Weight** | **<u>Fiscal Year 2022 Award Targets</u> <u><sup>(1)</sup></u>** | **<u>Fiscal Year 2022 Award Targets</u> <u><sup>(1)</sup></u>** | **<u>Fiscal Year 2022 Award Targets</u> <u><sup>(1)</sup></u>** | **Fiscal Year** <br> **2022** <br> **Results** | **Payout as a** <br> **% of Target** <br> **Incentive** |
| **Goal ($ in** <br> **millions)** | **Weight** | **Threshold** | **Target** | **Maximum** | **Fiscal Year** <br> **2022** <br> **Results** | **Payout as a** <br> **% of Target** <br> **Incentive** |
| **Total Revenue** | 40% | $228.3 | $248.1 | $268.0 | $244.8<sup>(1)</sup> | 91.5% |
| **ARR** | 40% | $207.7 | $225.8 | $243.9 | $208.0<sup>(1)</sup> | 50.7% |
| **Non-GAAP Operating Income** | 20% | $3.2 | $3.7 | $4.3 | $- | 0% |
| **Payout (as a % of target annual bonus opportunity)** |  | 50% | 100% | 150% |  |  |
| **Weighted Average payout as a % of Target** |  |  |  |  |  | **56.9%** |

---

<sup>(1)</sup> Fiscal year 2022 targets and actuals reflect financial figures in constant currency.

------

*2022 Payouts*. Although the strict financial metrics would suggest a bonus payout at the 56.9% level, the Compensation Committee has the authority to provide a discretionary component based on additional circumstances. In this case, the Compensation Committee, after discussion with management, determined to adjust the bonus payout to 70%, which resulted in an incremental $182,745 of aggregate bonus compensation to the named executive officers due to the following circumstances: (1) the named executive officers' shift to drive to greater efficiency and profitability during the second half of 2022, which resulted in additional short term expense for the benefit of long term profitability and (2) the named executive officers' additional focus on initiatives such as four completed mergers following the review of numerous other acquisition targets.

Actual payouts to each of the named executive officers in February 2022 were calculated as follows:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Executive Officer** | **2022 Base** <br> **Salary** | **Target**<br> **Annual Cash**<br> **Incentive (as**<br> **a % of**<br> **Base Salary)** | **Target**<br> **Annual Cash**<br> **Incentive** | **Annual Cash** <br> **Incentive**<br> **Payout**<br> **Percentage** | **2022 Annual** <br> **Cash**<br> **Incentive** |
| Xunkai Gong | $400000 | 100% | $400000 | 70% | $280000 |
| Tianyi Jiang | $450000 | 80% | $360000 | 70% | $252000 |
| Brian M. Brown | $350000 | 100% | $350000 | 70% | $245000 |
| James Caci <sup>(1)</sup> | $315000 | 90.5% | $285000 | 70% | $199500 |

---

<sup>(1)</sup> Per his employment agreement. Mr. Caci's target Annual Cash Incentive amount is $285,000 which equates to 90.5%.

**<u>Long-Term Equity Compensation</u>** 

We believe that long-term equity compensation provides appropriate motivational tools to achieve certain long-term company goals. The long-term equity compensation plan is designed to align the interests of named executive officers with those of stockholders, motivate each named executive officer to achieve key financial goals and reward superior performance. The design of the program, which also applies to the larger employee base, helps to reduce turnover and to retain the knowledge and skills of AvePoint's valued employees. In structuring the amount of long-term equity compensation awards, the Compensation Committee seeks to balance such awards and the interests of AvePoint's stockholders under a policy that moderates the dilutive effects of annual equity awards against the need to provide attractive and competitive incentive compensation.

The Compensation Committee approves annual equity awards to named executive officers and other key employees at the February Compensation Committee meeting, with the grant date following in March after the blackout is lifted. The Company does not time the grant in coordination with the release of material non-public information.

*Elements of Long-Term Equity Compensation:* 

*Time-Based RSUs.* RSUs are similar to time-based restricted shares, with the principal difference being that with RSUs, the shares are not actually issued until vesting. The RSUs have a four-year vesting period, vesting one-fourth after the first year with the remaining three-fourths vesting quarterly over the next twelve quarters. The number of RSUs granted is based on the approved target dollar amount of the award, divided by the fair market value of AvePoint's common stock on the date of the grant. Upon vesting, each RSU will equal the right to receive one share of AvePoint's stock.

RSUs facilitate retention by providing value if the named executive officer remains with AvePoint over the vesting period. In addition, RSUs provide alignment with stockholders through stock ownership, and the potential for future growth.

*Stock Options.* Stock options ("options") are grants which give the holder the right to receive stock in AvePoint upon paying the exercise price determined at the time of grant. The grant price is the closing market price of AvePoint's common stock on the grant date. Options have a four-year vesting period, vesting one-fourth after the first year with the remaining three-fourths vesting quarterly over the next twelve quarters. The number of options issued is based on the approved target dollar amount of options to be awarded, divided by the value of one option, which is equal to the Black-Scholes value of an equivalent stock option. Options have a term of ten years.

------

Options motivate executive efforts to achieve results that produce long-term increases (since executives have up to 10 years to exercise their options) in common stock. The four-year option vesting period encourages named executive officers to work with a long-term view of AvePoint's performance and reinforces their long-term affiliation with AvePoint. Named executive officers receive value in the option grants only when the share price increases above the grant price, which strengthens their alignment with stockholder interests.

The award agreements for RSUs and stock options provide that if a participant's employment with AvePoint is terminated due to death, permanent and total disability, retirement, by AvePoint without "cause," or by the participant with "good reason" (with "cause" and "good reason" being defined in the award agreements), any unvested awards held by a participant at termination will vest. The award agreements and the change in control provisions in the employment agreements further provide that in the event of a change in control of AvePoint, any unvested awards held by the participant at the time of the change in control will vest immediately.

*2021 Equity Awards*. In connection with the Apex Business Combination, making AvePoint a public company, and in recognition of such a milestone in our growth, AvePoint made a broad-based equity award in the form of RSUs to over 1,500 AvePoint employees globally with a goal of promoting ownership as shareholders. For our named executive officers and other senior leaders in the company, the award consisted of 50% stock options and 50% RSUs, vesting over four years. The award values were determined in consultation with Lockton Companies, Inc., the Company's independent compensation consultant at the time, and based on data of newly public companies. The award values for the named executive officers were specific to the year of the initial public offering and are not representative of future target award values.

*2022 Equity Awards*. In February 2022, the Compensation Committee considered each named executive officers' role, market data and awards made in 2021 in connection with the Apex Business Combination on July 2, 2021, making AvePoint a public company. With all factors weighted, the Compensation Committee made a determination to make the awards as set forth in the table below in fiscal year 2022:

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Named Executive Officer** | **Year** | **Option Award** <br> **Value (US$)<sup>(1)</sup>** | **RSU Award Value**<br> **(US$)<sup>(2)</sup>** | **Total Value (US$)** |
| Xunkai Gong | 2022<br> 2021 | 375000<br> 2999997 | 1125003<br> 3069293 | 1500003<br> 6069290 |
| Tianyi Jiang | 2022<br> 2021 | 375000<br> 2999997 | 1125003<br> 3069293 | 1500000<br> 6069290 |
| Brian M. Brown | 2022<br> 2021 | 107501<br> 2499999 | 322500<br> 2557740 | 430001<br> 5057739 |
| James Caci | 2022<br> 2021 | 225000<br> - | 675000<br> 999996 | 900000<br> 999996 |

---

<sup>(1)</sup> The amounts reported in this column represent the aggregate grant date fair value of service-based option grants awarded to the named executive officers in 2022 and 2021, calculated in accordance with FASB ASC Topic 718. Such grant date fair values do not take into account any estimated forfeitures related to service-vesting conditions. This calculation assumes that the named executive officer will perform the requisite service for the award to vest in full as required by SEC rules. The assumptions used in calculating the grant date fair values of the equity awards reported in this column are set forth in Note 14 of our audited Consolidated Financial Statements for the year ended December 31, 2022, appearing in the Annual Report on Form 10-K for the year ended December 31, 2022. The amounts reported in this column reflect the accounting cost for these equity awards and do not correspond to the actual economic value that may be realized by our named executive officers upon the vesting of the stock options, the exercise of the stock options or the sale of the common stock underlying such stock options*.*

<sup>(2)</sup> The amounts reported in this column represent the aggregate grant date fair value of service-based RSU grants awarded to the named executive officer in 2021 and 2022, calculated by reference to the closing price of our Common Stock on the grant date of such awards (March 21, 2022 and September 1, 2021, respectively) as reported on Nasdaq.

------

&nbsp;&nbsp;&nbsp;&nbsp;**Perquisites** 

The Company does not provide any perquisites to its named executive officers.

The Compensation Committee oversees the design, implementation and administration of all AvePoint benefit programs, including the grant of perquisites, if there ever are any.

&nbsp;&nbsp;&nbsp;&nbsp;**Additional Information on our Program** 

**<u>Anti-Hedging and Anti-Pledging within the Insider Trading Policy</u>**

The Board adopted in July 2021 an Insider Trading Policy that prohibits our executive officers from purchasing any financial instrument or entering into any transaction that is designed to hedge or offset any decrease in the market value of AvePoint equity (including, but not limited to, prepaid variable forward contracts, equity swaps, collars, or exchange funds), or pledging, hypothecating, or otherwise encumbering AvePoint equity as collateral for indebtedness.

**<u>Severance or Change-in-Control Agreements with named executive officers</u>**

The named executive officers have severance provisions in their respective employment agreements, which provide for certain benefits upon an involuntary termination. These agreements promote retention of high-performing individuals and also assist in recruiting and retaining key employees by providing competitive arrangements. In addition, equity awards provided to these named executive officers provide for an acceleration of equity grants upon a change in control of AvePoint. Change in control provisions are designed to protect executives in the event of a change in control and provide security for executives against sudden or arbitrary termination in connection with a change in control. The provisions of each agreement were determined by analysis of peer group and market trends and practices and are set at competitive levels with industry practice.

**<u>Decisions regarding each element affect decisions regarding the other elements</u>**

The Compensation Committee considers total cash and equity compensation when setting the compensation of executive officers. In doing so, the Compensation Committee considers the retention value of the long-term equity currently held by the executive. Based on this review, the Compensation Committee may decide to adjust one or more elements of an executive's total compensation. The Compensation Committee aims to provide competitive total direct compensation and assesses an executive's total compensation package when looking at the executive's competitive standing relative to the market. Additionally, the Compensation Committee seeks to provide a competitive compensation mix, with discretion depending on factors deemed relevant to the Compensation Committee, such as individual performance, internal equity, and historical pay practices. Certain compensation decisions may specifically affect other elements of compensation. For example, because potential annual cash incentive and long-term equity incentive payouts are based on the executive's base salary, increases in base salary also increase the amount of such payouts.

**<u>Tax and accounting considerations that factor into decisions regarding executive compensation</u>**

We consider tax and accounting implications in determining our compensation programs.

*Policy on Deductibility of Named Executive Officer Compensation.* Although the Compensation Committee has historically attempted to structure executive compensation to preserve deductibility, it also reserves the right to provide compensation that may not be fully deductible in order to maintain flexibility in compensating named executive officers in a manner consistent with our compensation philosophy, as deemed appropriate. The Compensation Committee believes that stockholder interests are best served by not restricting the Compensation Committee's discretion in this regard, even though such compensation may result in non-deductible compensation expenses to AvePoint.

------

*Internal Revenue Code Section 409A.* The Company reviews its compensation plans and programs for compliance with Section 409A of the Internal Revenue Code and the relevant Treasury Resolutions regarding nonqualified deferred compensation.

**Report of the Compensation Committee of the Board of Directors of AvePoint, Inc.** 

------

The Compensation Committee of the Board of Directors (the "***Board***") of AvePoint, Inc. ("***AvePoint***") has reviewed and discussed with AvePoint's management the Compensation Discussion and Analysis above, and recommended to the Board that the Compensation Discussion and Analysis be included in AvePoint's 2023 Proxy Statement.

Respectfully submitted, THE COMPENSATION COMMITTEE Jeff Epstein, Chairperson Jeff Teper Janet Schijns

The following tables, narrative and footnotes discuss the compensation of the Executive Chairman, Chief Executive Officer, Chief Financial Officer, and our other most highly compensated executive officer, during 2022. These individuals were the only executive officers of AvePoint during 2022 for whom this information is required under U.S. Securities and Exchange Commission ("***SEC***") rules.

**Summary Compensation Table** 

------

The following table provides information regarding total compensation awarded to, earned by, and paid to our named executive officers for services rendered in all capacities for the fiscal years ended December 31, 2022, and 2021. All figures shown are in U.S. Dollars.

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| **Named Executive** <br> **Officer** | **Year** | **Salary <sup>(1)</sup>** | **Stock** <br> **Awards <sup>(2)</sup>** | **Option** <br> **Awards <sup>(3)</sup>** | **Non-equity**<br> **incentive plan** <br> **compensation <sup>(4)</sup>** | **Total** |
| Xunkai Gong | 2022 | 400000 | 1125003 | 375000 | 280000 | 2180003 |
|  | 2021 | 380000 | 2999997 | 3069293 | 360000 | 6809290 |
| Tianyi Jiang | 2022 | 450000 | 1125003 | 375000 | 252000 | 2202003 |
|  | 2021 | 390000 | 2999997 | 3069293 | 324000 | 6783290 |
| Brian Michael Brown | 2022 | 350000 | 322500 | 107501 | 245000 | 1025001 |
|  | 2021 | 295000 | 2499999 | 2557740 | 315000 | 5667739 |
| James Caci | 2022 | 315000 | 675000 | 225000 | 199500 | 1414500 |
|  | 2021 | 113481 | 999996 | - | 118125 | 1231602 |

---

<sup>(1)</sup> Salary amounts reflect the actual base salary payments made in fiscal years 2022 and 2021, as applicable to the named executive officer.

<sup>(2)</sup> The amounts reported in this column represent the aggregate grant date fair value of service-based RSU grants awarded to the named executive officer in 2022 and 2021, calculated by reference to the closing price of our common stock on the grant date of such awards (March 21, 2022 and September 1, 2021, respectively) as reported on Nasdaq and calculated in accordance with FASB ASC Topic 718.

<sup>(3)</sup> The amounts reported in this column represent the aggregate grant date fair value of service-based option grants awarded in 2022 and 2021, calculated in accordance with FASB ASC Topic 718. Such grant date fair values do not take into account any estimated forfeitures related to service-vesting conditions. This calculation assumes that the named executive officer will perform the requisite service for the award to vest in full as required by SEC rules.

------

<sup>(4)</sup> The amounts reported in this column represent performance-based bonuses paid under the annual incentive plan for 2022 and 2021.

See the Compensation Discussion and Analysis above for a description of the material terms of each grant disclosed in the table above.

**Outstanding Equity Awards at Fiscal-Year End** 

------

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Named**<br> **Executive**<br> **Officer** | **Grant** <br> **Date** | **Outstanding** <br> **Options (#)** | **Vested Options (#)** | **Unvested** <br> **Options**<br> **(#)** | **Option** <br> **Exercise**<br> **Price (US$)** | **Option** <br> **Expiration** <br> **Date** | **Outstanding**<br> **Unvested**<br> **RSUs (#)** | **Vested** <br> **RSUs** <br> **(#)** | **FMV on** <br> **RSU Grant**<br> **Date (US$)** |
| **Xunkai Gong** | 01-Jul-2016 | 205913<sup>(2)</sup> | 205913 | 0 | $1.3357 | 01-Jul-2026 | - | - | - |
|  | 01-Jul-2016 | 743529<sup>(3)</sup> | 743529 | 0 | $1.3357 | 01-Jul-2026 | - | - | - |
|  | 10-Jan-2019 | 158647<sup>(2)</sup> | 126054 | 32593<sup>(1)</sup> | $1.5866 | 10-Jan-2029 | - | - | - |
|  | 10-Jan-2019 | 362840<sup>(3)</sup> | 362840 | <sup>(1)</sup> | $1.5866 | 10-Jan-2029 | - | - | - |
|  | 12-Aug-2020 | 259839<sup>(2)</sup> | 0 | 259839 | $3.9049 | 12-Aug-2030 | - | - | - |
|  | 12-Aug-2020 | 1468471<sup>(3)</sup> | 972173 | 496298<sup>(1)</sup> | $3.9049 | 12-Aug-2030 | - | - | - |
|  | 12-Aug-2020 | 391741<sup>(4)</sup> | 220354 | 171387<sup>(1)</sup> | $3.9049 | 12-Aug-2030 | - | - | - |
|  | 12-Aug-2020 | 184326<sup>(5)</sup> | 103697 | 80629<sup>(1)</sup> | $3.9049 | 12-Aug-2030 | - | - | - |
|  | 01-Sep-2021 | 749888<sup>(3)</sup> | 234240 | 515548<sup>(1)</sup> | $9.64 | 01-Sep-2031 | - | - | - |
|  | 01-Sep-2021 | - | - | - | - | - | 213951 | 97252 | $9.64 |
|  | 21-Mar-2022 | - | - | - | - | - | 191327 | 0 | $5.88 |
|  | 21-Mar-2022 | 138250 | 0 | 138250 | $5.88 | 21-Mar-2032 | - | - | - |
| **Tianyi Jiang** | 01-Jul-2016 | 299435<sup>(2)</sup> | 299435 | 0 | $1.3357 | 01-Jul-2026 | - | - | - |
|  | 01-Jul-2016 | 569707<sup>(3)</sup> | 569707 | 0 | $1.3357 | 01-Jul-2026 | - | - | - |
|  | 10-Jan-2019 | 126042 | 32592<sup>(1)</sup> | 95613<sup>(1)</sup> | $1.5866 | 10-Jan-2029 | - | - | - |
|  | 10-Jan-2019 | 362850 | 0<sup>(1)</sup> | 67350<sup>(1)</sup> | $1.5866 | 10-Jan-2029 | - | - | - |
|  | 12-Aug-2020 | 0 | 259840 | 259840 | $3.9049 | 12-Aug-2030 | - | - | - |
|  | 12-Aug-2020 | 1461068 | 876547<sup>(1)</sup> | 1525913<sup>(1)</sup> | $3.9049 | 12-Aug-2030 | - | - | - |
|  | 12-Aug-2020 | 220354 | 171387<sup>(1)</sup> | 269323<sup>(1)</sup> | $3.9049 | 12-Aug-2030 | - | - | - |
|  | 12-Aug-2020 | 103697 | 80648<sup>(1)</sup> | 126712<sup>(1)</sup> | $3.9049 | 12-Aug-2030 | - | - | - |
|  | 01-Sep-2021 | 234340 | 515340<sup>(1)</sup> | 749888<sup>(1)</sup> | $9.64 | 01-Sep-2031 | - | - | - |
|  | 01-Sep-2021 | - | - | - | - | - | 213951 | 97525 | $9.64 |
|  | 21-Mar-2022 | - | - | - | - | - | 191327 | 0 | $5.88 |
|  | 21-Mar-2022 | 138250 | 0 | 138250 | $5.88 | 21-Mar-2032 | - | - | - |
| **Brian Michael Brown** | 01-Jul-2016 | 82803<sup>(2)</sup> | 166197 | 24449<sup>(1)</sup> | $1.3357 | 01-Jul-2026 | - | - | - |
|  | 10-Jan-2019 | 190646<sup>(2)</sup> | 200467 | 0<sup>(1)</sup> | $1.5866 | 10-Jan-2029 | - | - | - |
|  | 10-Jan-2019 | 200467<sup>(3)</sup> | 166197 | 24449<sup>(1)</sup> | $1.5866 | 10-Jan-2029 | - | - | - |
|  | 12-Aug-2020 | 268913<sup>(2)</sup> | 0 | 268913 | $3.9049 | 12-Aug-2030 | - | - | - |
|  | 12-Aug-2020 | 593304<sup>(3)</sup> | 475000 | 118304<sup>(1)</sup> | $3.9049 | 12-Aug-2030 | - | - | - |
|  | 12-Aug-2020 | 146181<sup>(4)</sup> | 83230 | 632951<sup>(1)</sup> | $3.9049 | 12-Aug-2030 | - | - | - |
|  | 12-Aug-2020 | 68770<sup>(5)</sup> | 38694 | 30076<sup>(1)</sup> | $3.9049 | 12-Aug-2030 | - | - | - |
|  | 01-Sep-2021 | 624906<sup>(3)</sup> | 195284 | 429622<sup>(1)</sup> | $9.64 | 01-Sep-2031 | - | - | - |
|  | 01-Sep-2021 | - | - | - | - | - | 178292 | 81044 | $9.64 |
|  | 21-Mar-2022 | - | - | - | - | - | 54847 | 0 | $5.88 |
|  | 21-Mar-2022 | 39632 | 0 | 39632 | $5.88 | 21-Mar-2032 | - | - | - |
| **James Caci** | 01-Sep-2021 | - | - | - | - | - | 51864 | 51870 | $9.64 |
|  | 21-Mar-2022 | - | - | - | - | - | 114796 | 0 | $5.88 |
|  | 21-Mar-2022 | 82950 | 0 | 82950 | $5.88 | 21-Mar-2032 | - | - | - |

---

<sup>(1)</sup> This option vests as to 25% of the shares underlying the option on the first anniversary of the date of grant, with the remainder vesting in 12 equal quarterly installments thereafter.

<sup>(2)</sup> Represents the portion of this annual option grant that was made as an "incentive stock option" award. The award was fully vested as of July 1, 2020.

<sup>(3)</sup> Represents the portion of this annual option grant that was made as a non-statutory stock option. The award was fully vested as of January 10, 2020.

<sup>(4)</sup> This performance-based option vests upon the achievement of specified performance objectives relating to our financial metrics for the year ending December 31, 2021, as compared to the year ended December 31, 2020. This performance objective was met, and the option now vests as to 25% of the shares underlying the option on the first anniversary of the date of grant, with the remainder vesting in 12 equal quarterly installments thereafter.

<sup>(5)</sup> This performance-based option vests upon the achievement of specified performance objectives relating to individual performance throughout the 2020 year. This performance objective was met, and the option now vests as to 25% of the shares underlying the option on the first anniversary of the date of grant, with the remainder vesting in 12 equal quarterly installments thereafter.

<sup>(6)</sup> Represents a one-time option grant in 2020 that replaced earlier option grants that were due to expire before the end of 2020. As a result, the number of stock options granted is higher than it would have been in the absence of this additional one-time option grant.

------

**<u>Emerging Growth Company Status</u>**

We are an "emerging growth company," as defined in the JOBS Act. As an emerging growth company, we are exempt from certain requirements related to executive compensation, including the requirements to hold a nonbinding advisory vote on executive compensation and to provide information relating to the ratio of total compensation of our Chief Executive Officer to the median of the annual total compensation of all of our employees, each as required by the Investor Protection and Securities Reform Act of 2010, which is part of the Dodd-Frank Act.

**<u>Pension Benefits</u>**

Our named executive officers did not participate in, or otherwise receive any benefits under, any pension or retirement plan sponsored by us during 2022.

**<u>Nonqualified Deferred Compensation</u>**

Our named executive officers did not participate in, or earn any benefits under, a nonqualified deferred compensation plan sponsored by us during 2022.

**<u>Employment Agreements</u>**

In January of 2021, we entered into employment agreements with three of our named executive officers: Xunkai Gong, who serves as our Executive Chairman, Tianyi Jiang, who serves as our Chief Executive Officer and Brian Michael Brown, who serves as our Chief Legal and Compliance Officer. In August of 2021, we entered into an employment agreement with James Caci, who serves as our Chief Financial Officer.

For a discussion of the severance pay and other benefits to be provided in connection with a termination of employment under the arrangements with our named executive officers, please see "*Potential Payments Upon Termination or Change in Control*" below.

*Term*. The employment agreements with each of the named executive officers provide for at-will employment for an initial term of three years. Following the initial term, the employment agreements will automatically renew for successive one-year terms unless either party provides the other with at least 60 days' notice of intent not to renew before the expiration of the applicable term.

*Annual Bonus (Non-Equity Incentive Plan Compensation in the Summary Compensation Table above)*. Each named executive officer is eligible to receive annual cash bonus with a target amount equal to a percentage of his then current annual base salary (as described in the Compensation Discussion and Analysis section), payable dependent on the achievement of corporate performance goals as established by our Compensation Committee, and such named executive officer's continued performance of services through December 31 of the applicable bonus year.

*Equity Awards*. The named executive officers are also eligible to receive awards of stock options or other equity awards pursuant to any plans or arrangements maintained by us. Such equity awards are subject to accelerated vesting upon certain circumstances as discussed in "—*Potential Payments Upon Termination or Change in Control*" below.

*Benefits*. Each of the named executive officers are eligible to participate in our standard employee benefit plans and programs.

**<u>Potential Payments Upon Termination or Change in Control</u>**

Pursuant to the terms of the employment agreements, if a named executive officer's employment is terminated or his employment agreement is not renewed by us without "Cause" or such named executive officer resigns employment for "Good Reason" (each, as defined in the applicable employment agreement), and subject to delivery of a separation agreement including a general release of claims in favor of us, each named executive officer will be entitled to (i) an amount equal to his then current base salary and annual bonus (based on the average of his annual bonus earned in the two years prior to his termination) payable on each of our regularly scheduled payroll dates for up to eighteen (18) months (depending on the named executive officer, or in the case of Mr. Gong, twenty four (24) months) after his termination or resignation date, (ii) the cost of COBRA continuation coverage for all health plans and programs that such named executive officer participated in immediately prior to his termination until the earliest of up to (A) eighteen (18) months (depending on the named executive officer, or in the case of Mr. Gong, twenty four (24) months) following his termination or resignation date, (B) the date when he becomes eligible for substantially equivalent health insurance coverage in connection with new employment, or (C) the date he ceases to be eligible for COBRA continuation coverage for any reason, and (iii) immediate vesting of all unvested equity awards (excluding any equity award subject to the achievement of any performance-based or other vesting criteria other than time- or service-based vesting) that otherwise would have vested during the eighteen (18) month period following such named executive officer's termination or resignation.

------

In the event that a named executive officer's employment is terminated due to his death or "Disability", by us for "Cause", by such named executive officer other than for "Good Reason", or due to the "Discontinuance of Business" (each as defined in the applicable employment agreement), the named executive officer or his estate will not be entitled to any severance benefits or any other compensation or benefits other than (i) the payment of any accrued but unpaid salary, (ii) any unreimbursed business expenses, and (iii) any benefits owed under a qualified retirement, health, or welfare benefit plan in which such named executive officer was a participant in accordance with applicable law and the provisions of such plan.

In addition to the foregoing, each named executive officer is entitled to full vesting of their outstanding equity awards if they (i) remain in "Continuous Service" to us through the closing of a "Change in Control" (each as defined in the then current equity incentive plan), or (ii) are terminated without "Cause" or resign for "Good Reason" during the three-month period immediately prior to the closing of a change in control. In order to receive any such acceleration, the applicable named executive officer must execute a general release of claims in favor of us, and allow such release to become effective.

**Equity Compensation Plan Information** 

------

The following table sets forth the following information as of December 31, 2022, for all equity compensation plans previously approved by AvePoint's stockholders:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;■ the number of securities to be issued upon the exercise of outstanding options, warrants and rights;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;■ the weighted average exercise price of such outstanding options, warrants and rights; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;■ other than securities to be issued upon the exercise of such outstanding options, warrants and rights, the number of securities remaining available for future issuance under the plans. The following table shows certain information with respect to all of our equity compensation plans in effect as of December 31, 2022:

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Equity compensation**<br> **plans approved by** <br> **stockholders<sup>(1)</sup>** | **Number of**<br> **securities to be**<br> **issued upon**<br> **exercise of**<br> **outstanding RSUs and**<br> **stock options**<br> **(1)** | **Weighted-**<br> **average**<br> **exercise price**<br> **of outstanding**<br> **stock options**<br> **(2)** | **Weighted-**<br> **average**<br> **grant date fair value**<br> **of outstanding**<br> **RSUs**<br> **(3)** | **Number of**<br> **securities remaining**<br> **available for**<br> **issuance under**<br> **equity compensation**<br> **plans (excluding**<br> **securities reflected**<br> **in column (4))** |
| AvePoint, Inc. 2021 Equity Incentive Plan<sup>(2)</sup> | 16681131 | $7.26 | $7.20 | 20298497 |
| AvePoint, Inc. 2016 Equity Incentive Plan | 20014041 | $2.82 | NA | 0<sup>(3)</sup> |
| AvePoint, Inc. 2006 Equity Incentive Plan | 858063 | $1.65 | NA | 0<sup>(4)</sup> |

---

<sup>(1)</sup> The equity compensation plans approved by security holders are described in Note 14 – Stock-Based Compensation to our financial statements included in our Annual Report on Form 10-K for the year ended December 31, 2022 and include the AvePoint, Inc. 2021 Equity Incentive Plan (the "***2021 Plan***"), the AvePoint, Inc. 2016 Equity Incentive Plan (the "***2016 Plan***"), and the AvePoint, Inc. 2006 Equity Incentive Plan (the "***2006 Plan***"), which were all approved by AvePoint's stockholders.

<sup>(2)</sup> The number of shares reserved for issuance under the 2021 Plan automatically increases on January 1st of each year, beginning January 1, 2022, and continuing through January 1, 2031, by the lesser of (a) 5.0% of the total number of shares of the Company's common stock outstanding on December 31st of the immediately preceding fiscal year or (b) a lesser number determined by the Board prior to the applicable January 1st.

<sup>(3)</sup> As of the effective date of the 2021 Plan, no further stock awards have been or will be made under the 2016 Plan.

<sup>(4)</sup> As of the effective date of the 2016 Plan, no further stock awards have been or will be made under the 2006 Plan.

------

**The Company**'**s Compensation Policies and Practices as** <br> **They Relate to Risk** 

------

The Company does not believe that its compensation policies and practices create risks that are reasonably likely to have a material adverse effect on AvePoint. The annual cash incentive compensation plan described in the Compensation Discussion and Analysis section above is based upon achievement of annual financial targets, and potential cash incentive compensation opportunities are tempered so as not to place a disproportionate incentive on short-term financial results. In addition, the long-term equity incentive plan provides appropriate motivation to achieve long-term financial results as well, given that the ultimate value of the award is based upon the future value of AvePoint's stock, and such awards constitute a significant portion of each executive's total compensation package. The Company has constructed the performance factors in short- and long-term performance plans such that they balance focus on performance metrics with strong links to stockholder value creation and overall company performance, which we believe avoids any potential risks that may result from an imbalance in performance metrics.

**Advisory Vote on Executive Compensation** 

**(Proposal 2)** 

------

The Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010, or the Dodd-Frank Act, enables our stockholders to vote to approve, on an advisory (non-binding) basis, the compensation of our named executive officers as disclosed in this Proxy Statement, in accordance with the SEC's rules.

As described in detail under the heading "*Compensation Discussion and Analysis*," our executive compensation programs are designed to attract, motivate, and retain our named executive officers, who are critical to our success. Under these programs, our named executive officers are rewarded for the achievement of specific annual, long-term and strategic goals, corporate goals, and the realization of increased stockholder value. Please read the "*Compensation Discussion and Analysis*" section above for additional details about our executive compensation programs, including information about the fiscal year 2020 compensation of our named executive officers.

The Compensation Committee periodically reviews the compensation programs for our named executive officers to determine and confirm that they achieve (and continue to achieve) the desired goals of aligning our executive compensation structure with our stockholders' interests and current market practices.

We are asking our stockholders to indicate their support for our named executive officer compensation as described in this Proxy Statement. This proposal, commonly known as a "say-on-pay" proposal, gives our stockholders the opportunity to vote on our named executive officers' compensation. This vote is not intended to address any specific item of compensation, but rather the overall compensation of our named executive officers and the philosophy, policies and practices described in this Proxy Statement.

The say-on-pay vote is advisory, and therefore not binding on AvePoint, the Compensation Committee or our Board. Our Board and our Compensation Committee value the opinions of our stockholders, and the Compensation Committee will consider the results of the vote in future decisions relating to executive compensation.

 **Approval of Proposal 2**

Approval of this proposal will require the affirmative vote of holders of a majority of the shares of common stock present in person or represented by proxy and entitled to vote on such matter at the annual meeting. Unless authority to do so is withheld, it is the intention of the persons named in the proxy to vote such proxy **FOR** this proposal. Abstentions from voting on this proposal will have the same effect as a vote against this proposal. Brokers may vote their shares on this proposal if they have voting instructions from the beneficial owners of the shares. Broker non-votes will not be treated as votes cast on this matter, and therefore will not have any effect on determining the outcome.

------

**The Board unanimously recommends that the stockholders of AvePoint vote FOR the approval of the compensation of our named executive officers, as disclosed in this Proxy Statement.** 

**Report of the Audit Committee of the Board of Directors of AvePoint, Inc.** 

------

John Ho, Janet Schijns, and Jeff Teper are members of the Audit Committee. Each of the members of the Audit Committee is considered independent under the Nasdaq listing standards and under the SEC's audit committee independence standards. Mr. Ho serves as Chairperson of the Audit Committee.

The Audit Committee operates under a written charter adopted by AvePoint's Board.

During the fiscal year ended December 31, 2022, the Audit Committee of the Board of AvePoint reviewed with AvePoint's financial managers, the internal auditors and Deloitte, AvePoint's independent registered public accounting firm, the scope of the annual audit and audit plans, the results of internal and external audit examinations, the evaluation of AvePoint's system of internal controls, the quality of AvePoint's financial reporting, and AvePoint's process for legal and regulatory compliance. The Audit Committee also monitored the progress and results of the testing of internal control over financial reporting pursuant to Section 404 of the Sarbanes-Oxley Act of 2002, as amended.

Management is responsible for AvePoint's system of internal controls, the financial statements and the financial reporting process, and the assessment of the effectiveness of internal control over financial reporting. Deloitte is responsible for performing an integrated audit and issuing reports on AvePoint's consolidated financial statements. As provided in its charter, the Audit Committee's responsibilities include monitoring and overseeing these processes. The Audit Committee has reviewed and discussed the audited consolidated financial statements for the fiscal year ended December 31, 2022, with management. The review included, among other things:

● Deloitte reports to the Audit Committee regarding the conformity of AvePoint's consolidated financial statements with U.S. Generally Accepted Accounting Principles;

● Areas of audit emphasis, particularly those presenting the greatest risk of material misstatement to AvePoint's consolidated financial statements;

● The process used by management in formulating particularly sensitive accounting estimates and the basis for Deloitte's conclusions regarding the reasonableness of these estimates;

● The existence of, if any, audit adjustments and uncorrected consolidated financial statement misstatements; and

● Other material written communications between the independent registered public accounting firm and management.

Deloitte also communicated to the Audit Committee in writing any relationships between Deloitte and AvePoint and persons in financial reporting oversight roles at AvePoint and provided confirmation of their independence with respect to AvePoint as required under the Public Company Accounting Oversight Board (the "***PCAOB***") rules and relevant professional and regulatory standards.

Consistent with this oversight responsibility, Deloitte reports directly to the Audit Committee. The Audit Committee appointed Deloitte as AvePoint's independent registered public accounting firm and approved the firm's compensation.

The Audit Committee discussed with Deloitte the matters required to be discussed by the Nasdaq, the SEC, the PCAOB. In addition, the Audit Committee has received from Deloitte the written disclosures and the letter required by the applicable requirements of the PCAOB regarding the independent accountants' communications with the Audit Committee concerning independence and discussed with Deloitte the firm's independence from AvePoint and its management.

In reliance on the review and discussions referred to above, the Audit Committee recommended to the Board, and the Board has approved, the inclusion of the audited consolidated financial statements in AvePoint's Annual Report on Form 10-K for the fiscal year ended December 31, 2022, for filing with the SEC.

Respectfully submitted, THE AUDIT COMMITTEE John Ho, Chairperson Janet Schijns Jeff Teper

------

**Independent Registered Public Accounting Firm** 

------

&nbsp;&nbsp;&nbsp;&nbsp;**Fees** 

**Appointment of Deloitte** 

The Board approved the appointment of Deloitte as AvePoint's independent registered accounting firm for part of the fiscal year ending December 31, 2021, and all of the fiscal year ending December 31, 2022.

Prior to that appointment, for the years 2021, Deloitte and its affiliates had performed several other services for AvePoint and its affiliates, including transfer pricing analyses, pre-SPAC technical accounting consulting, transaction cost recovery services with respect to the Apex Business Combination, tax advisory services, and individual income tax compliance and advisory services with respect to AvePoint's equity incentive plans.

Deloitte considered whether the matters noted above impacted its objectivity and ability to exercise impartial judgment with regard to its engagement as AvePoint's auditors and has concluded that there has been no impairment of Deloitte's objectivity and ability to exercise impartial judgment on all matters encompassed within its audits. Deloitte believed and currently believes that a reasonable investor with knowledge of all relevant facts and circumstances would reach the same conclusion. Likewise, the Audit Committee considered whether Deloitte's provision of the foregoing non-audit services was compatible with maintaining Deloitte's independence, and in each occurrence determined none of the engagements would interfere with or otherwise impair Deloitte's independence.

Based on the information provided by Deloitte, after taking into consideration the facts and circumstances of the above matters and Deloitte's conclusion, AvePoint, the Audit Committee, and the Board also concluded that Deloitte's objectivity and ability to exercise impartial judgment was not and has not been impaired.

**Principal Accountant Fees and Services**

The following table presents the aggregate fees billed by Deloitte, as our principal accountant, for the fiscal years ended December 31, 2021 and 2022.

---

| | | |
|:---|:---|:---|
|  | **2021** | **2022** |
| Audit services | $1320000 | $1359000 |
| Audit-related services | $23548 | $89633 |
| Tax services | $63069 | $636355 |
| All other services | $--- | $--- |
| Total | $1406617 | $2081988 |

---

*Audit Services.* Audit services include services performed by Deloitte to comply with the standards of the Public Company Accounting Oversight Board ("***PCAOB***") related to the audit and review of our consolidated financial statements. The audit fees shown above for the 2021 and 2022 fiscal years were incurred principally for services rendered in connection with the audit of our consolidated financial statements and associated SEC filings and quarterly reviews.

*Audit-Related Services.* Audit-related services include assurance and related services that are traditionally performed by independent registered public accounting firms outside of the PCAOB audit scope.

------

*Tax Services.* Tax services include services in connection with the preparation of our tax returns and corporate tax consultations.

*All Other Services*. All other services consist of permitted services other than those that meet the criteria above.

&nbsp;&nbsp;&nbsp;&nbsp;**Pre-Approval Policy** 

The Audit Committee pre-approves all audit and permissible non-audit services provided by AvePoint's independent registered public accounting firm. These services may include audit services, audit-related services, tax and other services. Pre-approval on other than an engagement-by-engagement basis is generally provided for up to one year, and any pre-approval is detailed as to the particular service or category of services and is generally subject to a specific budget. The independent registered public accounting firm and management are required to report periodically to the Audit Committee regarding the extent of services provided by such firm in accordance with this pre-approval and the fees for the services performed to date. The Audit Committee also may pre-approve particular services on an engagement-by-engagement basis.

During the year, circumstances may arise when it may become necessary to engage the independent registered public accounting firm for additional services not contemplated in the original pre-approval. In those instances, the Audit Committee requires specific pre-approval before engaging the independent registered public accounting firm. The Audit Committee has the authority to delegate pre-approval authority to a subcommittee of the Audit Committee consisting of one or more of its members.

All services provided to AvePoint by Deloitte during fiscal 2021 and 2022 were pre-approved by the Audit Committee in accordance with this policy.

**Ratification of Appointment of Independent Registered** <br> **Public Accounting Firm for the 2023 Fiscal Year**

**(Proposal 3)** 

------

The Audit Committee of the Board has appointed Deloitte as AvePoint's independent registered public accounting firm for AvePoint's fiscal year ending December 31, 2023. The Board is submitting this appointment for stockholder ratification at the annual meeting.

A representative of Deloitte will attend the annual meeting, will have the opportunity to make a statement and will be available to respond to appropriate questions from stockholders.

The Company's bylaws do not require that stockholders ratify the appointment of Deloitte as AvePoint's independent registered public accounting firm. The Company is asking its stockholders to ratify this appointment because it believes such a proposal is a matter of good corporate practice. If the stockholders do not ratify the appointment of Deloitte, the Audit Committee will reconsider whether or not to retain Deloitte as AvePoint's independent registered public accounting firm but may determine to do so. Even if the appointment of Deloitte is ratified by the stockholders, the Audit Committee may change the appointment at any time if it determines that a change would be in the best interests of AvePoint and its stockholders.

&nbsp;&nbsp;&nbsp;&nbsp;**Approval of Proposal 3**

Approval of this proposal will require the affirmative vote of holders of a majority of the shares of common stock present in person or represented by proxy and entitled to vote on such matter at the annual meeting. Unless authority to do so is withheld, it is the intention of the persons named in the proxy to vote such proxy **FOR** this proposal. Abstentions from voting on this proposal will have the same effect as a vote against this proposal. Broker non-votes will not be treated as votes cast on this matter, and therefore will not have any effect on determining the outcome.

------

**The Board unanimously recommends that the stockholders of AvePoint vote FOR the ratification of the appointment of Deloitte as AvePoint**'**s independent registered public accounting firm for the 2023 fiscal year.** 

**Transactions with Related Persons** 

------

On June 29, 2021, AvePoint's Board approved and adopted a written policy for the approval of transactions with related persons (the "***Related Person Transaction Policy***"). The Related Person Transaction Policy requires Board or Audit Committee approval or ratification of any transaction, arrangement or relationship (or any series of similar transactions, arrangements or relationships)_in which AvePoint and any Related Person (as defined by the Related Person Transaction Policy and 17 CFR § 229.404 (Item 404)), directly or indirectly, are, were or will be participants in which the amount involved exceeds the lesser of (a) $120,000 USD or (b) one percent of the average of AvePoint's total assets at year-end for the last two completed fiscal years ("***Related Person Transaction***"). Transactions involving compensation for services provided to AvePoint as an employee, consultant or director shall not be considered Related Person Transactions under the Related Person Transaction Policy. Nor shall a transaction, arrangement or relationship in which the Related Person's participation is solely due to the Related Person's position as an director of an entity that is participating in such transaction, arrangement, or relationship be considered a Related Person Transaction. Under the Related Person Transaction Policy, any proposed transaction that has been identified as a Related Person Transaction may be consummated or materially amended only following approval by the Board or the Audit Committee in accordance with the requirements of the Related Person Transaction Policy. In the event that it is inappropriate for the Audit Committee to review the transaction for reasons of conflict of interest or otherwise, after taking into account possible recusals by Audit Committee members, then the Related Person Transaction shall be approved by the Board or another independent body of the Board.

Any director who has a direct or indirect material interest in the proposed Related Person Transaction must not participate in any action regarding whether to approve the Related Person Transaction and must not be present during deliberations concerning the Related Person Transaction unless the transaction related to the remuneration of the director is for director indemnification or insurance or is with an affiliate of AvePoint and the director's interest is solely that of a director of the affiliate. If, however, a proposed Related Person Transaction arises in which all directors are deemed to have a direct or indirect material interest in the transaction, the proposed Related Person Transaction shall be submitted to the stockholders for approval and the disclosure provided to the stockholders shall clearly identify each director's interests in the proposed Related Person Transaction.

***<u>Legacy AvePoint Related Party Transactions</u>***

<u>Put & Call Agreements</u>

In December 2019, Legacy AvePoint entered into put & call agreements with Brian Brown and certain other officers. The Put & Call Agreements granted to Mr. Brown and certain other officers put options to request redemption of up to 182,432 shares of Legacy AvePoint common stock during the period from March 26, 2025 to April 26, 2025 or, if earlier, the 30 day period following a qualifying termination, as defined in the Put & Call Agreements, for a redemption price per share equal to the fair market value of the shares, as determined by Legacy AvePoint's board of directors. The put & call agreements also granted Legacy AvePoint call rights to purchase up to the same number of shares from Mr. Brown at a purchase price equal to the fair market value of the shares, subject to the prior written consent of Avatar Investment and its affiliated entities as long as they continue to hold any shares of Legacy AvePoint Series C Preferred Stock.

The put & call agreements were terminated upon the closing of the Apex Business Combination.

<u>Series C Preferred Stock Financing</u>

In December 2019, Legacy AvePoint entered into a stock purchase and redemption agreement (the "***Series C SPA***") pursuant to which it issued and sold an aggregate of 4,832,409 shares of its Series C Preferred Stock to investors affiliated with Sixth Street at a purchase price of $31.0404 per share, for aggregate gross proceeds of $150.0 million.

------

At the same time, Legacy AvePoint entered into a non-voting common stock purchase agreement (the "***Non-Voting SPA***") with AVPT, LLC, one of Legacy AvePoint's former principal stockholders. Messrs. Gong and Jiang were managers of AVPT Manager, LLC, which was the sole manager of AVPT, LLC. Pursuant to the Non-Voting SPA, AVPT, LLC purchased 497,735 shares of Legacy AvePoint's common stock at a purchase price of $32.889 per share, for a total purchase price of $16.4 million. The transactions contemplated by the Series C SPA and the Non-Voting SPA are together referred to as the "Series C Financing." AVPT, LLC was dissolved in connection with the Apex Business Combination.

Immediately following the closing of the Series C Financing, Legacy AvePoint redeemed 2,631,842 shares of Series B-1 Convertible Preferred Stock and 2,385,032 shares of Series B-2 Convertible Preferred Stock for an aggregate of $165.0 million from entities affiliated with Goldman Sachs & Co., one of Legacy AvePoint's former principal stockholders.

***<u>Our Related Party Transactions</u>***

<u>A&R Registration Rights Agreement</u>

In connection with the closing of the Apex Business Combination, certain holders of our capital stock entered into an amended and restated registration rights agreement.

Under the Related Person Transaction Policy, the related person in question or, in the case of transactions with a holder of more than 5% of any class of our voting securities, an officer with knowledge of a proposed transaction, must present information regarding the proposed related person transaction to our Audit Committee (or, where review by our Audit Committee would be inappropriate, to another independent body of the Board) for review. To identify related person transactions in advance, we will rely on information supplied by our executive officers, directors and certain significant stockholders. In considering related person transactions, our Audit Committee will take into account the relevant available facts and circumstances, which may include, but are not limited to:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The risks, costs, and benefits to us;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The impact on a director's independence in the event the related person is a director, immediate family member of a director or an entity with which a director is affiliated;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The terms of the transaction;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The availability of other sources for comparable services or products; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The terms available to or from, as the case may be, unrelated third parties.

Our Audit Committee will approve only those transactions that it determines are fair to us and in our best interests. All of the transactions described above were entered into prior to the adoption of such Related Person Transaction Policy.

------

**Delivery of Documents to Stockholders Sharing an Address** 

------

If you and other residents at your mailing address own common stock through a broker or bank in "street name," your broker or bank may have sent you a notice that your household will receive only one Annual Report to stockholders and Proxy Statement or a Notice of Availability indicating proxy materials are available on the internet for each company in which you hold shares through that broker or bank. The practice of sending only one copy of an Annual Report to stockholders and Proxy Statement or a Notice of Availability is known as "householding." If you did not respond that you did not want to participate in householding, you were deemed to have consented to the process. If the foregoing procedures apply to you, your broker has sent one copy of the Notice of Availability to your address. You may revoke your consent to householding at any time by sending your name, the name of your brokerage firm, and your account number to Broadridge, Householding Department, 51 Mercedes Way, Edgewood, New Jersey 11717 (telephone number: 1-800-542-1061). In any event, if you did not receive an individual copy of AvePoint's Annual Report to stockholders or this Proxy Statement, and wish to do so, AvePoint will send a copy to you if you address your written request to AvePoint, Inc., 901 East Byrd Street, Ste. 900, Richmond, Virginia 23219, Attention: Secretary. If you are receiving multiple copies of the Annual Report to stockholders and Proxy Statement or Notice of Availability, you can request householding by contacting AvePoint in the same manner. The Company encourages you to participate in this program. It will reduce the volume of duplicate information received at your household, as well as reduce AvePoint's expense.

------

**Other Matters** 

------

The Board does not intend to present to the annual meeting any other matters not referred to above and does not presently know of any matters that may be presented to the meeting by others. If other matters are properly brought before the meeting, the persons named in the enclosed proxy will vote on such matters in their own discretion.

By Order of the Board of Directors,

![avpt20230323_def14aimg010.jpg](avpt20230323_def14aimg010.jpg)

Tianyi Jiang

*Chief Executive Officer*![avpt20230323_def14aimg011.jpg](avpt20230323_def14aimg011.jpg)

Brian M. Brown

*Chief Legal and Compliance Officer*<br> *and Secretary* 

Dated: March 24, 2023

------

![notice01.jpg](notice01.jpg)

------

![notice02.jpg](notice02.jpg)

------

![proxy1.jpg](proxy1.jpg)

------

![proxy2.jpg](proxy2.jpg)